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ABSTRACT 
Development of a simple, specific, sensitive and rapid RNA microchip for detection of 
Head and Neck Cancer (HNC) mRNA, pathogenic bacteria and dengue virus (DENV) RNA is 
reported. By use of nucleases and polymerases specific RNAs are selectively labeled and de-
tected without separation, reverse transcription and or polymerase chain reaction. This is ac-
complished by designing specific Hybrid probes consisting of DNA-2’-O-Me-RNA-DNA regions 
to target the RNA of interest. Upon hybridization with the target RNA, RNase H digestion is used 
to remove the 3’- RNA sequences which exposes the template for Klenow extension with re-
porter molecules such as hapten or fluorophore labels. This novel RNA microchip is fast (ca. 1 h 
detection time), selective as individual RNAs are detected in a synthetic mixture and total RNA 
mixtures, specific for single nucleotide polymorphisms (SNPs) discrimination and sensitive up to 
attomole level for chemiluminescence detection and lower femtomole for gold nanoparticles 
(AuNPs) and silver staining method. Using chemiluminescence, HNC biomarkers, VCAM1 and 
IL8 are specifically labeled and detected in the presence of thousands of other mRNAs in can-
cer cell lines and human colon cancer total RNA without interference. Furthermore, the method 
is highly specific as shown with DENV SNPs discrimination. 
Moreover, we report rapid (ca 1hour), selective, specific multi-marker detection of patho-
genic mRNAs and HNC mRNAs using AuNPs-silver staining on the RNA microchip. Streptavidin 
gold nanoparticles technology has a potential in the analysis of specific mRNAs in a wide array 
of field including infectious diseases diagnosis, viral infections, food safety, gene expression 
profiling and cancer detection. A simple and rapid NaOH RNA extraction procedure was devel-
oped for E. coli total RNA extraction with specific results on the RNA microchip using both 
chemiluminescence and AuNPs silver staining. This extraction avoids the use of commercial 
RNA purification kits thus reducing the cost. Furthermore, visual detection on the RNA micro-
chip is simple, does not require electricity or special equipment, and therefore is a good candi-
date for field diagnostics with minimum resources. 
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1 
1. NUCLEIC ACID DETECTION METHODS 
1.1 Introduction 
Nucleic acid detection methods have become an important aspect in molecular biology 
to understand the status of the cells. Since the introduction of genome wide nucleotide se-
quence determination, nucleic acid detection methods have seen unprecedented growth. Nucle-
ic acids assays find application in molecular biology methods including gene expression profil-
ing, pathogen detection, medical, forensic and environmental field. Advances in nucleic acid 
technology have yielded many analytic procedures that allow quantification of rare transcripts to 
qualitative analysis of the status of the cell by analyzing thousands of transcripts. The current 
qualitative tools can also allow analysis of the human genome in one microarray experiment. 
The range and the scope of nucleic acids applications continue to expand with more sophisti-
cated methodologies being developed to cater for the more increasing biological questions. 
1.2 Biological background 
A cell is the basic structural and functional unit of all known living organism. The cell 
contains the nucleus where hereditary information is stored on the chromosome. The chromo-
somes are made up of deoxyribonucleic acids (DNA) which codes the hereditary information in 
a double stranded helix. The genetic information is encoded as a sequence consisting of four 
nucleotides; guanine, adenine, thymine, and cytosine normally abbreviated as using the letters, 
A, G, C and T. All organisms except some RNA viruses are built from these four components. 
The common use of DNA and the genetic code by all organisms underlies one of the most pow-
erful discoveries of the past century: organisms are remarkably uniform at the molecular level. 
Each chromosome contains between several hundred and many thousands of genes. A gene is 
a DNA fragment that codes for a protein. Each cell contains same set of chromosomes and 
technically same set of genes. Irrespective of these, there is a wide variety in appearance. 
2 
This is explained by the central dogma of molecular biology which explains the flow of 
genetic information.1 First, the gene is transcribed into ribonucleic acids (RNA) and to be specif-
ic, messenger RNA (mRNA; Figure 1.1). The next step involves translation of mRNA to a pro-
tein. Most proteins undergo modification after translation and before becoming functional pro-
teins. This coupled with different level of transcription among cell types, pre-translational pro-
cesses on the mRNA and thus different levels of translation among cell types lender the differ-
ences observed in the appearances of the cell, tissues, organs and finally organisms. Detection 
of proteins would therefore indicate the difference between cells but most proteins undergo 
modification after translation and before becoming functional. These post translational modifica-
tions render direct relationship of the amount of proteins and the cell status difficult. Protein 
based approaches are also more difficult, less sensitive and have lower throughput. The mRNA 
detection therefore bears a close relationship to the state of the cell thus making the 
transcriptome worth of measurement. Through mRNA detection, one can understand the cell 
state, changes in mRNA abundance as a result of protein levels as well as monitoring gene ex-
pression profiles changes as a result of cellular perturbations. This can lead to better under-
standing of what goes on in normal cells and will find an application in the study of cancerous 
cells which have been linked to changes in the cell environment. 
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Figure  1.1: The central dogma of life. DNA-RNA-Protein 
 
1.3 Nucleic acid hybridization 
Technically, all nucleic acid methods in molecular biology exploit a potent feature of the 
DNA; the ability of two complimentary strands or sequence to come together to form a duplex. It 
is remarkable that a molecule of such great structural complexity can reassemble to form a hy-
brid with perfect fidelity from separated complimentary strands under the appropriate conditions 
i.e. temperatures and salt. This process is referred to as nucleic acid hybridization. Hybridization 
requires the two sequences involved to have a degree of complementarity which also deter-
mines the stability of the duplex. Nucleic acid hybrids can be formed between two strands of 
DNA, two strands of RNA, or a hybrid between one strand of DNA and one of RNA. The extent 
and the rate of hybridization are influenced by several factors including the composition of the 
sequences, the length of the sequences, degree of complexity, as well as hybridization condi-
tions. Presence of mutations also lowers the stability of the duplex formed. The stability of du-
plex formation is often determined from the melting temperature (Tm) of the hybrid which is the 
4 
temperature at which half of the DNA strands are in the random coil or single-stranded DNA 
(ssDNA) state. 
Nucleic acid hybridization provides a means for detecting any isolated nucleic acid such 
as a viral genome, pathogens genome, cancer mRNA, microRNA or RNA by designing a com-
plimentary DNA or RNA sequences that are complementary to the target. By fine tuning the fac-
tors affecting hybridization, any sequence can be specifically detected. There are various meth-
ods taking advantage of hybridization for detection of nucleic acids, specifically mRNA including 
northern blots, S1 nuclease protection assay, reverse transcription-polymerase chain reaction, 
serial analysis of gene expression, nucleic acid sequence based amplification and of recent, 
DNA microarrays. The methods tries to answer a few questions; how much mRNA is tran-
scribed, abundance of mRNAs and other types of RNAs, the function, the presence of mutation 
and how the variations in that sequence lead to increased risk for diseases. This chapter out-
lines methods specifically designed for RNA detection 
1.4 Northern blot 
Northern blot analysis is a classical method for analysis of the size and steady-state lev-
el of a specific RNA in a complex sample. Northern transfer is the equivalent of southern trans-
fer procedure for DNA analysis.2 Once the target RNA is extracted, it is separated by denaturing 
gel electrophoresis, then transferred to a nitrocellulose filter (Figure 1.2).3 The specific RNA 
species are detected by hybridization with a radioactively-labeled probe. The intensity of the au-
to radiographic signal is a measure of the concentration of the target RNA while the migration 
distance is a measure of its molecular weight. The first northern blot was first performed on a 
diazotized paper.4 
Northern blot is frequently used in gene expression studies. The method is relatively 
simple to perform, inexpensive, and not plagued by artifacts. The membranes can also be 
stored and reused after many years. With the availability of the northern blots publications in 
Blot Base, sharing of information is possible which facilitates research in the area. Initially, only 
5 
one gene could be analyzed at a time. The problem is that the method provides no information 
as to the copy number of RNA species hybridizing to the probe. Northern blot usually look at 
one or a small number of genes making it unsuitable for large scale analysis. 
 
Figure  1.2: The detection of RNA from D. melanogaster using 32P labeled probe (Thomas 
et al., 1980). 
 
1.5 Nuclease protection assays (NPAs) 
Nuclease protection assays (S1 nuclease and RNase protection) are sensitive proce-
dures for detection and quantification of mRNA species. They are well suited for 5’ and 3’ map-
ping, determining the positions of external and internal junctions in RNA and can be used to dis-
criminate between closely related targets. The method was initially used to determine the loca-
tion and size of intervening sequences in eukaryotic mRNA.5 NPAs uses a probe DNA/RNA to 
protect the target RNA from nucleases. When the probe is a DNA molecule, S1 nuclease is 
used and when the probe is RNA, any single stranded specific RNases e.g. RNase H can be 
used.6 7 7b The choice of the probe depends on the nuclease available. 
The first step in an NPA experiment is the choice of target RNA followed by extraction of 
the RNA from a biological sample. The RNA is then hybridized to a complimentary probe of 
choice (Figure 1.3). The probe that spans the predicted RNA terminus or splice point can be 
6 
prepared by cloning part of the gene of interest. The restriction fragment is then purified and 
end-labeled with 32P.8 The probe is then denatured and hybridized with the RNA of interest. Af-
ter hybridization, the reaction mixture is incubated with nuclease that specifically cleaves the 
single stranded segments of the probes leaving double stranded fragments. The products are 
separated on a denaturing gel electrophoresis and detected by autoradiography. The intensity 
of the band is proportional to the concentration of the complimentary RNA if the probe was used 
in excess. Non-isotopic probes can also be used, in which case the samples are visualized by 
transferring the gel to a membrane and performing secondary detection. 
NPA analysis is easy to use and can allow multiple target assays. The method is more 
sensitive than the Northern blotting and is more tolerant to partially degraded RNA. The main 
problem is the non-specific cleavage observed as nuclease S1 may cut at AT-rich region in the 
probe causing spurious bands down the lower region of the gel.9 Also multiple bands are often 
seen which may be attributed to heterogeneity at the 5’- and 3’- ends of the RNA or 
exonucleolytic cleavage of the DNA-RNA hybrid. 
 
Figure  1.3: The principle of nuclease protection assay using 5’- end-labeled probe. 
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1.6 Polymerase chain reaction (PCR) 
PCR is a biochemical technology for amplification of a single or a few copies of DNA in a 
mixture. Developed in 1983 by Kary Mullis at Cetus Corporation in California, PCR has become 
a common technique in biochemical sciences with a wide range of applications.10 Basically, 
PCR consists of repetitive cycles of denaturation, hybridization, and polymerase extension re-
sulting in an enrichment of a DNA sequence up to a factor of 106. PCR amplification involves 
two oligonucleotides also referred to as, primers, which flank the DNA fragment to be amplified. 
These primers hybridize to opposite strands of the target sequence allowing doubling of target 
by the polymerase after each cycle. The thermal denaturation step regenerates the primers and 
templates setting in a motion of a chain reaction with an exponential accumulation of targets, 
approximately 2n copies. 
One major drawback of the invention was the thermal instability of the DNA polymerase 
causing inactivation on heating. This required separation of the primers and addition of more 
polymerase at the start of each cycle thus reducing the efficiency of the amplification. But dis-
covery of Thermus Aquaticus (Taq), a thermostable DNA polymerase purified from the 
thermophilic bacterium revolutionalized the technique.11 12 13 Taq polymerase is a stable enzyme 
at heat denaturing temperature i.e. 95 oC. Taq polymerase therefore allowed the chain reaction 
to be done continuously. This modification not only increased the yield, sensitivity and specificity 
but also paved way for automation. Amplified sequences can be detected by a variety of meth-
ods including gel electrophoresis and ethidium bromide staining. Usually, final detection of PCR 
products rely on hybridization methods using DNA probes.14 15 
The method that formed the cornerstone of the human genome project has created an 
imaginable opportunities, with many developments and several patents. Quantitative PCR 
(qPCR), also quantitative real time PCR (RT-PCR), one of the most common variant of PCR 
allows the amplified products to be detected as the reaction progresses in real time i.e. after 
every cycle. Detection is accomplished by use of intercalating dyes e.g. fluorescent dyes or use 
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of specific reporter probes.16 17 18 19 qPCR eliminates post-PCR manipulations that add time to 
the analysis and may also introduce errors. 
1.6.1 Reverse transcription PCR (RT-PCR) 
RT-PCR, one of the many variant of PCR is used to qualitatively measure RNA expression 
levels.20 For detection of RNA sequences, a preceding reverse transcriptase (RT) step is re-
quired (Figure 1.4). RT translates RNA into a cDNA sequences which can serve as a template 
for PCR amplification. Although this RT step complicates the procedure considerably, RT-PCR 
has been used successfully for the detection of many RNA sequences in the biological and bi-
omedical sciences. Currently, real-time RT-PCR analysis is the gold standard for RNA detection 
in the fields of fundamental research, drug discovery and molecular diagnostics. Quantitative 
RT-PCR can also be used for RNA quantification.21 18 
The technique is highly sensitive and has a wide dynamic range. Even though RT-PCR 
allows analysis of several genes, this requires designing of amplification standards for each 
gene and characterization of each reaction kinetics. In addition, RT-PCR usually requires two 
separate reactions, RT and PCR, in different buffers and temperatures. This step not only in-
creases the handling time but also introduces the risk of cross-contamination among samples. 
Although several one-step RT-PCR reagents are commercially available and allow both RT and 
PCR in a single tube without sample dilution or transfer between the reactions, two-step RT-
PCR is generally more sensitive and specific than the one-step reaction format. One of the ma-
jor problems with the one-step reaction format is primer dimerization or mis-priming formation 
during the RT step, which deteriorates the sensitivity and accuracy of the following PCR reac-
tion. This is problematic especially with real-time PCR using SYBR Green.22 
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Figure  1.4: RT-PCR. RNA is first transcribed to DNA followed by PCR. 
 
1.7 Nucleic acid sequence based amplification (NASBA) 
Developed in 1991 by J. Compton, NASBA is a method in molecular biology that is used 
to amplify RNA sequences.23 Compton defined it as a primer-dependent technology that can be 
used for the continuous amplification of nucleic acids at constant temperature. Unlike PCR 
which uses repeated thermal denaturation of double-stranded DNA thus requiring specialized 
thermal cyclers, NASBA is accomplished at an isothermal temperature, normally 41 oC (Figure 
1.4). 
NASBA makes use of simultaneous enzymatic activities of avian myeloblastosis virus 
reverse transcriptase, RNase H and T7 RNA polymerase. The method requires two short single 
stranded DNA primers derived from opposite sides of the target RNA. Once RNA is introduced 
into the reaction mixture, reverse transcriptase synthesizes the complimentary DNA strand, fol-
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lowed by the RNase H cleavage of the RNA template. Consequently, T7 RNA polymerase pro-
duces a complementary RNA strand that can be re-used in step 1 thus initiating a cyclic amplifi-
cation process. NASBA can allow amplification of up to a billion fold in two hours. The 
isothermic temperature control allows each step to proceed as soon as an intermediate be-
comes available. Products of NASBA are single stranded and, thus can be applied to detection 
formats using probe hybridization without further treatment. 
Immediately after invention, NASBA was applied for rapid diagnosis of HIV-1 which ena-
bled detection of 10 molecules of target RNA.24 Van Der Meide et. al., comparison of NASBA, 
Real-Time RT-PCR and Real Time PCR favored qRT-PCR over NASBA.25 Nevertheless, the 
method has undergone various modifications since discovery to allow even multiplex analysis 
as reported by Mader et al., in the detection of microRNAs coupled with biochips.26 
 
Figure  1.5: Schematic presentation of NASBA method. 
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1.8 Serial analysis of gene expression (SAGE) 
SAGE was developed in mid 1990 by Velculescu et al., for the analysis and identification 
of many genes simultaneously.27 This came at a time when determination of genomic sequenc-
es required a method that would allow rapid identification of many genes and their abundance. 
Technically, SAGE allows quantitative and simultaneous analysis of a large number of tran-
scripts without any prior information. 
First the mRNA of the target of interest is isolated followed by sequence tags selection 
from a defined position of each mRNA (Figure 1.6). Two tags are then ligated, followed by liga-
tion with many tags, as many as 70 to 100 tags per concatemer. The concatemer sequences 
are cloned and later sequenced in parallel which allows the identification of several sequences 
in one shot. Thereafter, SAGE software is used to extract the tags from the sequences of 
concatemer clones. These tags are then matched to the genome which identifies the corre-
sponding gene. The output reflects the gene expression patterns and the abundance of each 
tag in the RNA population. SAGE generates nucleotide sequence tags with sufficient infor-
mation to match the genome and identify a transcript. The results can also give information for 
potentially undiscovered genes or exons. 
Originally, short tags, 9 to 10 base pairs were used which allowed efficient analysis of 
thousands of transcripts in a serial manner but several variants have been developed since. 
Most notably, a more robust version developed by Saha et al., allows production of longer tran-
scripts tags even though it is limited to lower cloning efficiency and small inserts.28 Robust-long 
SAGE, an improvement of long SAGE can generate over 4.5 million tags from a small amount 
of mRNA using just 20 ditag PCR products.29 
The major advantage of SAGE is that the output is digital so the data obtained can be di-
rectly compared between labs and researchers. SAGE also allows both qualitative and quantita-
tive evaluation of thousands of genes without any prior information thus it is a powerful global 
approach for analyzing gene expression profiles and discovery of genes. On the other hand, 
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SAGE is relatively time consuming and expensive thus it is generally not the preferred method 
for large scale analysis. The technique is similar to expressed sequence tags (EST) sequencing 
except the sensitivity is high. 
 
Figure  1.4: Schematic presentation of serial gene expression analysis. 
 
1.9 Molecular beacons 
Molecular beacons (MBs), first proposed in 1996 by Tyagi and Kramer are a hairpin-
structured oligonucleotide probes containing an internally quenchable fluorophore and a 
quencher at different ends of the strand (Figure1.7).30 MBs consists of a loop which is comple-
mentary to the target sequence, a stem at both termini of the loop made of 5-7 nucleotide resi-
dues complimentary to each other, a fluorophore at the 5’-end and a quencher at the 3’-end. 
The stem keeps the quencher and the fluorophore in close proximity to each other causing the 
fluorescence to be quenched by either fluorescence energy transfer (FRET) or collisional 
quenching.31 Detection occurs when a target RNA sequence hybridizes with the loop causing 
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dissociation of the fluorophore from the quencher thus resulting in restoration of fluorescence 
emission. Since unhybridized MBs are dark, MBs can be used in homogeneous assays and in 
living cells without separation. MBs have been widely used in many areas such as the detection 
of PCR products, mutational analysis, clinical diagnosis, genotyping and SNPs discrimination.32 
The first reported MBs consisted of an 18-base loop section and a 5-base-pair stem with 
5-(2’-aminoethyl) aminonaphthalene-1-sulfonic acid (EDANS) as a fluorophore and 4- (4’-
dimethylaminophenylazo) benzoic acid (DABCYL) as the quencher.30 Incomplete quenching of-
ten reduced the sensitivity of MBs thus requiring increased research to improve MBs technolo-
gy. Organic dyes, quantum dots and pyrene excimer have been envisioned as better performing 
MB components. Quantum dots are nanocrystal structures made of CdSe and CdTe cores. 
They have high quantum yields, narrow, symmetric and stable photoluminescence, tunable ad-
sorption and emission which makes them attractive as fluorophores.32 Yeh et al described use 
of CdSe-ZnS core-shell QDs and gold nanoparticles quenchers for detection of infectious virus 
RNA.33 
 
Figure  1.5: Molecular beacons principle. In the presence of a complementary target RNA 
sequence, the beacon unfolds, hybridizes with the target, and exhibits fluorescence that 
is easily detectable. 
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1.10 Detection on microchip 
Detection on the chip also referred to as DNA microarray is a very attractive method for 
RNA analysis. This is accomplished by use of cDNA to indirectly detect RNA. This method ena-
bles detection of thousands of mRNAs in an RNA mixture. With the unparalleled high density 
detection, the method was a great tool in the discovery of human genomes among other ge-
nomes. 
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2. DNA MICROARRAY 
2.1 Overview of DNA microarray technology 
The completion of human genome among other genomes provided a lot of data with 
many intriguing questions on how it functions. These generated a great interest in the study of 
functions and expression profiles of the many genes discovered. But, many of the nucleic acid 
methods available at the time worked on “one gene one experiment” principle, thus limiting the 
impact of the results. SAGE and NASBA, the currently available multiplex technologies offered 
great promise but they had limited development and acceptance. The methods required the 
identified genes to be sequenced and analyzed in a serial fashion. These procedures were time 
and labor intensive and prone to false positives. There was therefore a challenge to find a cost 
effective platform that would enable analysis of thousands of genes simultaneously, and still 
maintain a high level of sensitivity and specificity. The development of DNA microarray technol-
ogy in the mid 1990s was therefore a promise to help monitor the whole genome as well as elu-
cidate the purposes of the genes discovered. 
A DNA microarray also referred to as DNA microchip or hybridization array can be 
thought of as a miniaturized gene detection assay that allow monitoring of expression levels of 
thousands of genes simultaneously. As the name suggests, DNA microarray represents DNA 
fragments attached to a solid surface in an ordered manner at a high density. The high density 
is made possible by miniaturization of detection from macro to micron level. For example, the 
DNA fragments spot size range from 20 to 200 µm as opposed to more than 5000 µm observed 
in micro titer plates experiments. This enables printing of thousands of micron spots on a micro-
scope slide. Thus it is possible to place the entire human genome compliment on one micro-
scope slide. 
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The principle behind DNA microarray technology is that RNAs from a given cell or organ-
ism is labeled and hybridized to DNA immobilized on a solid support. As with many other nucleic 
acid detection methods, microarray takes advantage of the formation of duplex in the presence 
of complementary sequences. The presence and abundance of specific target sequences within 
the sample of interest are indicated by the intensity of the hybridization signal. The RNA sample 
whose identity is being sought is referred to as a ‘target’ while the DNA sequences tethered on 
the surface are referred to as ‘probes’. 
Microarrays detection is a complex process involving many experimental and analysis 
steps; sample collection, total RNA or mRNA extraction, cDNA /cRNA synthesis and labeling, 
fabrication, hybridization, image capture, data processing, statistical analysis and biological veri-
fication. Microarray technology therefore is an example of the convergence of several technolo-
gies, including automated DNA sequencing, PCR, oligonucleotide synthesis, nucleic acid label-
ing chemistries and bioinformatics. The early days of microarray technology were filled with a lot 
of excitement due to the ability to detect many genes or samples simultaneously which was a 
departure from the current nucleic acid methods. This saw emergence of many platforms and 
variations but now the focus is in the applications and data quality.34 35 35b This chapter discuss-
es the most important aspects in the DNA microarray technology. 
2.2 Preparation of target RNA 
DNA microarray detection of RNA is an example of an indirect method for RNA detec-
tion. Even though the main target is RNA, indirect detection through cDNA is favored due to the 
complications associated with the nature of RNA. RNA is easily degraded by nucleases and has 
the capability to form complex secondary structures. This complicates handling and detection of 
RNA. Target preparation therefore involves reverse transcription of RNA into cDNA after RNA 
extraction from tissues or cells. A tag or label can be incorporated at this step. 
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2.3 Probe design 
The success of microarray experiment is determined by the design of the probes. Each 
probe presents a gene or a transcript of interest and is complimentary to the target. The objec-
tive of this step is to find target specific probes that hybridize under similar condition. The com-
pletion of several genomes provided a lot of information that opened a wide array of research in 
this field. The genome sequences are housed at the national center for biotechnology infor-
mation (NCBI) in Genbank. The database is available online through Entrez. Gene information 
can be obtained from these databases. Probes are designed to give a good representation of 
the target of interest, afford the highest hybridization signal and must be as specific as possible 
to minimize cross hybridization. The first and most widely used approach is to choose a probe 
sequence that is complimentary to your target and has little sequence similarity to all other 
available sequences. This requires screening of the millions of raw data with search engines 
such as basic local alignment search engine (BLAST). There are essentially two main types of 
probes: PCR products and oligonucleotide probes. 
2.3.1 PCR products 
Microarrays are mostly differentiated by the size of the probes. cDNA microarrays con-
sists of cDNA of about 500-2000 sequences obtained from cloned PCR products.36 The PCR 
products are purified to remove unwanted salts, detergents and proteins and run on gel to veri-
fy the clone size and purity to avoid cross contamination. The concentration is also determined 
to flag the suboptimal clones.37 The main drawback lie on the requirement to prepare a large 
number of cDNA or PCR products, which need to be purified, quantitated, and catalogued be-
fore spotting on the solid surface. The process can be labor intensive and is prone to many er-
rors. This were the probes of choice when the technology was first reported.38 39 
2.3.2 Oligonucleotide probes 
Oligonucleotide probes are normally shorter and can be obtained either by solid phase 
or in situ synthesis.36a, 40 41 The probes can be home made using standard solid phase 
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phosphoramidites chemistry on a DNA synthesizer. This comes with flexibility and affordability 
but control of the size among researcher is not standardized, thus data comparison might not be 
easy. Generally the size of the probes ranges from 25-70 bases long but shorter probes with 10 
bases have been used with enough specificity.42 43 44 The length of the probes is usually re-
stricted by the efficiency of the standard solid phase phosphoramidite chemistry.45 
2.3.3 In situ synthesis of oligonucleotide probes 
In situ synthesis methods are the most efficient method for high density oligonucleotide 
microarrays for gene expression profiling although can be limited in terms of flexibility and af-
fordability. The methods permit combinatorial synthesis of oligonucleotides on the solid surface 
nucleotide by nucleotide. This involves several repetitive steps of i.e.; deblocking, coupling, 
capping and oxidation. This is repeated until the full length probe is synthesized. Two major 
platforms exist; the Agilent Inkjet and the Affymetrix photolithography method. The Agilent 
Inkjet synthesis uses hydrophobic surfaces to block unreactive areas leaving exposed OH 
groups compatible with nucleic acid synthesis.46 Probes are synthesized using standard 
phosphoramidite chemistry to generate 60 bases long oligonucleotides. Comparison of spotted 
60mer microarrays and the Agilent cDNA microarrays gave highly consistent results.42 
2.3.4 Affymetrix photolithographic synthesis 
The Affymetrix GeneChip is the most widely used for gene expression profiling. The 
combinatorial technique combines solid phase oligonucleotide synthesis and photolithographic 
computer chip technology.41 47 48 The platform comprises of high-density standardized microar-
rays and instrumentation. Affymetrix method requires irradiation with UV light through holes of 
photographic masks on the surface to remove photo-labile protecting groups. Flooding of the 
surface with the four bases ensures coupling at the specific locations (Figure 2.1). The probes 
do not exceed 25 nucleotides due to reaction efficiencies limit. The method allows production 
of highly miniaturized microarrays with current arrays having a capacity of 1.3 million unique 
features per array of 5 in x 5 in. Specificity is compensated by synthesizing many oligonucleo-
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tides for each gene sequence paired with mismatched oligonucleotides that differs at the centre 
of the probe with one nucleotide. Multiple probes are designed to represent each transcript. 
The technology offers platforms for exon, gene or whole genome analysis. The method is high-
ly specific and reproducible but custom arrays are needed for each organism. 
 
Figure  2.1: Affymetrix In-situ synthesis (Fodol et al., 1991) 
 
2.4 Probe immobilization 
Irrespective of the type of probes used, they must be immobilized on a solid support for 
specific detection. The main distinction between dot blots and DNA microarrays is in the use of 
an impermeable, rigid substrate such as glass which are advantageous over porous mem-
branes or gel pads.49 As liquid cannot penetrate the support surfaces, surface hybridizations is 
enhanced. These speeds up the washing step thus improving reproducibility as well as reducing 
the background. The flatness and rigidity improves automation which facilitates image capturing 
and processing. 
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Suitable surfaces should have low intrinsic fluorescence, achieve high density and high 
hybridization signal. The surface should allow homogenous chemical funtionalization with high 
resistance to non specific adsorption. Planar solid supports allow accurate scanning and imag-
ing.50 The rigid impermeable quality of glass or silicon support enables automated manufacture 
with accurate distances and increased precision. The surfaces are amenable to chemical modi-
fications via well known silanization chemistries. Amongst all these surfaces, glass has been 
widely used due to its great chemical resistance and is easily available. Other surfaces include 
nylon/filter membranes, plastic materials and poly(methyl methacrylate) (PMMA).51 52 
Immobilization on the planar surface can be achieved either by printing pre-synthesized 
molecules 48 53 54 or by in situ synthesis. Probes require suspension in appropriate buffer before 
printing. The purpose of the buffer is to promote uniform delivery, increase printing efficiency, 
reduce sample evaporation, increase visibility of the spots and provide the right condition for 
immobilization chemistry. Nucleic acids form a monolayer on the solid surface. Interactions of 
the solution phase with the immobilized probes are much faster thus accelerating hybridization 
and washing procedures. These not only improves reproducibility but also reduces 
background.55 
Various microarraying robots deposit the probes in an ordered grid with predetermined 
columns and rows. Printing can be accomplished by either contact or non-contact printing. The 
former uses pin in contact with the surface while the latter accomplishes deposition without di-
rect contact with the surface. Non contact printing applies ink-jet printer’s principle to dispense 
single drops of the probes (Figure 2.2).56 The main drawback with non contact printing is the 
occurrence of droplets outside the grid. Factors that influence the fabrication of DNA on modi-
fied surfaces include surface chemistry, probe concentration and spotting buffer. The probes 
should also be well spaced to enable maximum hybridization signal and avoid electrostatic in-
teractions. 
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Figure  2.2: Different probe immobilization methods (Van Hall et al., 2000). 
 
2.5 Surface coupling chemistry 
Oligonucleotides cannot be coupled directly to the surface silanol groups of silicon or 
glass. It is therefore necessary to functionalize the surface with a group that can easily be cou-
pled with an oligonucleotide probe or from which it is easy to initiate the growth of an oligonu-
cleotide chain in case of in situ synthesis. Tethering one end of an oligonucleotide to a surface 
leads to a loss of degree of freedom. Some of the drawbacks associated with the loss include, 
sterical hindrance, non-uniform coupling of the chemical layer, low probe density and inhomo-
geneous probe morphology. Thus a highly specific and efficient coupling reaction is required. 
There are myriad of coupling approaches including simple adsorption approaches and covalent 
modifications. 
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2.5.1 Adsorptive coupling techniques 
Adsorption immobilization is a noncovalent coupling method based on electrostatic, Van 
der Waals interactions, hydrogen bonding and hydrophobic interactions. With adsorption tech-
nique, there is no need to modify the probes thus reducing the cost of arrays.57 A widely used 
chemistry is avidin adsorption on the glass surface. Avidin modified surface affords immobiliza-
tion of biotinylated probes by the formation of electrostatic interactions, hydrogen bonds, Van 
der Waals and hydrophobic interactions. Avidin-Biotin interaction is one of the strongest 
noncovalent interactions. This method is however quite expensive due to the high amount of 
avidin and specific biotinylated probes required. Also avidin is susceptible to desorption at high 
temperatures and high ionic strength solutions.58 
Poly-L-lysine chemistry also affords electrostatic interaction of DNA on the surface. A 
positively charged lysine is grafted onto the surface. The DNA is bound on the surface through 
noncovalent interaction between the negatively charged phosphodiester groups of the DNA 
backbone and the positively charged amino functions of surface-bound lysine side-chains. The 
binding however is reversible thus resulting in decreased sensitivity. In addition, the electrostatic 
interactions reduce the conformational freedom of the bound cDNA thus reducing their affinity 
and specificity to the target molecules. Poly-L-lysine also desorbs on exposure to high or low pH 
solutions thus requiring pH control on the surface. The surface also ages fast thus affecting the 
hybridization yields. The DNA molecules can be cross-linked using UV light to form extra bonds 
which enhance the stability. This was the first chemistry to immobilize PCR products.38-39 Due to 
the high background resulting from non-specific adsorptions and low stability, non-covalent ad-
sorption methods are not widely used. 
2.5.2 Covalent coupling techniques 
The need for efficient chemistries for attachment of oligonucleotides on the surfaces led 
to great interest in covalent chemistries. Covalent coupling involves formation of a covalent 
bond between the probe and the solid surface. Technically, this will also involve the activation of 
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probes with functionalities that easily reacts with the modified surface. Immobilization on un-
modified is also possible with silanized nucleic acid 59 or propanolamine-derivatized oligonucleo-
tides.60 While use of unmodified glass afforded good results, the methods did not gain popularity 
with surface activation being the preferred method. 
An efficient coupling chemistry should be chemically stable; the linker should be long 
enough to avoid steric interference and well defined on the surface. A great number of attach-
ment chemistries have been developed.58 57 Generally, the substrates are usually subjected to 
silanization chemistries such as alkoxysilanes derivatives before introduction of the coupling 
chemistry. Silylation is a very attractive method for glass and silicon surface activation and is 
also an important step in further modification of surface. The most commonly used silanes are 
aminopropyl triethoxysilane, aldehyde-modified silanes, epoxy silanes and mercaptosilanes. 
Amino-modified oligonucleotides can be bound to aldehyde-activated surfaces61 38 epox-
ide62 or isothiocyanate functionalized surfaces.58, 63 Aldehyde modification involves amination of 
glass with a consequent step of glutaraldehyde which binds DNA by a Schiff base reaction. The 
amino silane linker lifts the DNA probes from the surface making it more accessible for incoming 
target. Epoxy funtionalization is also a very attractive method but printing of probes must be 
conducted in strongly alkaline solutions which convert amine to free base. This might lead to 
hydroxide formation during evaporation and siloxane degradation. 
Thiol-modified oligonucleotides, also commonly used can easily be immobilized on sur-
faces functionalized with maleimide groups such as heterobifunctional cross-linker succinimidyl 
4-[p-maleimidophenyl]butyrate (SMPB).64 65 Halo carbonyl compounds such as bromoacetamide 
or α-halo acetyl are also good surfaces for –SH modified oligoncueotides.66 67 Disulfide–
modified oligonucleotides on the other hand, can be immobilized on a mercapto-silanised glass 
support through a thio/disulfide exchange reaction.68 The disulphide bridges were found to be 
stable during contact with biological samples, hybridization conditions and PCR reactions.69 
24 
Use of dendrimeric structures have been reported to allow homogenous functionalization 
and increased binding capacity as a result of increased binding sites. However preparation of 
the three dimensional-linker is time consuming and often times generate a mixture of 
dendrimers. 50b, 63 70 
2.6 Detection methods 
Accurate signal transduction is imperative for gene expression studies. This mostly in-
volves introduction of a label in the system either using reverse transcriptase during preparation 
of cDNA or direct chemical labeling. Detection methods can be divided into two categories; ra-
dioactive and non radioactive. Radio-isotopic detection, a more traditional method, involves de-
tection of radio-isotopes. Non radioactive methods include chemiluminescence, fluorescence 
and electrical methods. With the advent of gold nanoparticles (AUNPs) technology, various de-
tection methods are feasible. 
2.6.1 Radioactive detection 
Radioactivity detection involves use of radioactive isotope in conjunction with an imaging 
plate/phosphoimaging system yielding a digital image of the radioactivity. X-ray film can also be 
used; however it requires long exposure times and the output is not digitalized.71 72 73 The probe 
of interest is labeled with an isotopic molecule, 32P which is imaged by radiographic film or 
phosphor imaging. Radioactive labeling is easy and sensitive but the labels are expensive to 
prepare and quite toxic.74 75 The method battle signal spreading from high spot densities which 
can complicate the dynamic range. Radioactive labels are also limited due to their short half 
life.76 77 
2.6.2 Fluorescence detection 
Target RNAs can be labeled during reverse-transcription using dUTPs with tagged fluo-
rescent dyes e.g. fluorescein and cyanine.76 39, 78 79 The cyanine derivatives, i.e. Cy3- and Cy5-
dUTP affords one or two channels detection using one or both dyes respectively (Table 1). Two 
channel involves labeling RNAs from two groups e.g. control and test samples with different flu-
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orescent markers. This improves precision and enables simultaneous detection and compara-
tive analysis of both test and control targets.38 Detection is accomplished by use of a confocal 
scanning microscope or charge coupled device (CCD) with different filters. The main drawback 
with confocal scanners is the use of expensive lasers for each excitation wavelength. CCD de-
tectors on the other hand can use a single light source with different filters to afford different ex-
citation wavelength. Agilent technologies comparison of the single and dual channel comparison 
showed high concordance.80 The MammaPrint, first FDA approved microarray-based gene ex-
pression assay is based on Agilent two-color platform.81 
2.6.3 Chemiluminescence detection 
Chemiluminescence detection is also an attractive method for microarray detection. The 
method uses an enzyme to catalyze a chemical reaction in the presence of a substrate. The 
Applied Biosystems microarrays employs digoxigen label and alkaline phosphatase-antibody 
conjugate for chemiluminescence detection.82 The addition of a substrate with an initiator and 
enhancer leads to chemiluminescence signal which can be captured with a CCD camera. The 
method has a high sensitivity and a wide dynamic range. 
2.6.4 Electrochemical detection 
Electrochemical detection couples bio-recognition step directly to the detector that gen-
erates a useful electrical signal. The devices can be cost effective and can be easily miniatur-
ized.83 84 Direct detection can be accomplished via the oxidation of the guanine bases.85 In con-
trast, indirect methods rely on interactions between nucleic acids and other molecules i.e. metal 
nanoparticles to generate a detectable signal. Tagging DNA with gold nanoparticles leads to 
conductivity changes associated with target-probe binding events. Silver deposition facilitated 
by gold nanoparticles leads to conductivity measurable signals.86 
2.6.5 Nanoparticles based detection 
Nanomaterials feature unique physicochemical properties that can be greatly utilized in 
creating new signal transduction processes in microarray technology. Gold nanoparticles 
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(AuNPs) have unique physical chemical properties that make them excellent reporter mole-
cules. Nucleic acid detection methods take advantage of the high AuNPs affinity for sulfur as 
well as their intense surface plasmon resonance associated with thiolated oligonucleotides func-
tionalized with AuNPs. Upon hybridization with the target, AuNPs afford various read out meth-
ods. Another approach is the use of functionalized protein probes e.g. streptavidin.87 Streptavi-
din labeled AuNPs offers an advantage over oligonucleotide labeled AuNPs since the latter in-
volves preparation of specific probes for each application. Use of AuNPs provides highly specif-
ic detection method of nucleic acids with various readout methods.88 89 Various applications in-
clude global gene expression profiling, pathogen detection, drug development and cancer ther-
apeutics.36a 38 
Table  2.1: Microarray gene expression platforms 
 
 
2.7 Applications 
DNA microarray has been a major tool in helping decode the genomes of various organ-
isms including pathogens and viruses. DNA microarray data have shown it is possible to group 
genes on the basis of expression patterns from which functional relationships can be deducted. 
This technology has therefore been applied in the study of expression patterns in disease diag-
nosis, prognosis, treatment outcome and progression studies. Simultaneous detection has been 
used in point mutations and single nucleotide polymorphisms (SNPs) analysis. The method has 
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steadily advanced and soon it might be a corner stone in medical applications and personalized 
medicine; e. g. MammaPrint for breast cancer detection.90 The major genetic risk factors for dis-
eases such diabetes, cancer, bipolar illness, Alzheimer’s and many others may be identified 
with array technology years to come. Other applications have been reported in food safety anal-
ysis and forensics. 
2.8 MicroRNA detection 
MicroRNAs (miRNAs) constitute a class of short RNAs discovered recently. miRNAs are 
initially transcribed as long precursor RNA molecules and successfully processed by Drosha 
and Dicer complexes into their mature forms of ~22 nucleotides.91 Only a few have a known 
function in the control gene expression post transcriptionally which is important for gene regula-
tion and proteins.92 93 The qualitative and quantitative expression levels of miRNAs are therefore 
expected to exert a profound regulatory influence on the transcriptome. Accurate detection of 
miRNAs is therefore important to investigate physiological states as well as elucidate their func-
tions. 
Different methodologies have been used to profile miRNA expression, including miChip 
with locked nucleic acids,94 surface Plasmon resonance imaging (SPRI),95 gold nanoparticles,96 
97 By contrast to mRNA profiling technologies, miRNA profiling must address the short nature or 
probes and should be able to discriminate SNPs. Detection using microarrays is therefore prob-
lematic requiring inclusion for highly specific probes. Use of locked nucleic acids (LNA) that bind 
more strongly to miRNA not only increase sensitivity but specificity on the microarrays.94 97 
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3. RNA MICROCHIP TECHNOLOGY 
 
3.1 Introduction 
Culture based detection methods and biochemical techniques can be quite time con-
suming taking 2-3 days and often can be inconclusive.98 In an effort to increase the sensitivity, 
speed and reliability of RNA detection, various nucleic acid based methods have been devel-
oped including but not limited to; RT-PCR,99 NASBA,100 differential display and cDNA microar-
rays.101 Though these genotypic approaches have allowed highly sensitive and specific RNA 
detection, they only offer an indirect measurement of RNAs requiring conversion to cDNA by 
RT-PCR followed by labeling. The cDNA synthesis not only increases detection time but intro-
duces multiple biases and artifacts that could interfere with both the proper characterization and 
quantification of RNA. cDNA synthesis is also not suitable for the analysis of short and degrad-
ed RNA which are not captured by the primers thus making them difficult to amplify and label.102 
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The direct detection of RNA therefore remains an important and challenging research 
goal. This work is based on the development of a simple, easy to use, rapid and cost effective 
mRNA detection chip. Other than pathogen detection, the RNA microchip will be a great tool in 
functional genomics studies and the analysis of how mutations produce genetic disorders or in-
crease risks for a disease. The RNA microchip could also be adapted for point of care diagnos-
tics (POCs). 
Development and validation of an RNA biosensor was investigated. Chapter 4 outlines 
application in head and neck cancer detection as our model using chemiluminescence detec-
tion. Chapter 5 discusses detection of E. coli total RNA, Chapter 6 discusses the application in 
dengue virus serotyping. Development of visual RNA chip facilitated by gold nanoparticles and 
silver staining is outlined in chapter 7. 
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3.2 Target selection 
There is a wide range of fields that require molecular diagnostics to determine the status of 
the cell, causative agents or the effects thereof. These include but are not limited to food safety, 
recreational water safety, animal health care, pathology, clinical diagnostics, forensics research 
and bio-defense. Infectious diseases and cancer to mention a few account for >25% of all caus-
es of death (Figure 3.1).104 Development of rapid, sensitive and specific assays for cancer and 
infectious diseases is therefore an important task. Bacterial and pathogens epidemics pose a 
significant threat to human, animal and agricultural health. For example the highly pathogenic 
strain of Escherichia coli (E. coli) (O157:H7) is the main cause of food borne illness, therefore 
epidemic monitoring and detection of E. coli in food production and recreational water is very 
important. 
 
 
Figure  3.1: Infectious diseases and cancer diseases accounts for >25% of all illnesses. 
 
3.2.1 Probe sequence selection 
Gene selection is an important step to ensure selective and specific information is ob-
tained from the experiments. The gene should be specific and should give empirical evidence of 
the status of the target. An example is lethal factor of the Bacillus anthracis (B. anthracis). Once 
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the gene of interest has been selected, the target sequence of the genes can be obtained from 
the NCBI which houses the genome sequencing data in Genbank. This is followed by probe de-
sign. 
Our probe sequences are mostly between 15 - 40 nucleotides. This length has been 
shown to be long enough to be target specific. This sequence length is well suited for solid 
phase phosphoramidite synthesis and gel electrophoresis purification. Shorter probes have 
been shown to increase hybridization yields too. Once a region is selected, we use BLAST to 
search for sequence similarity.105 BLAST compares the sequence against all the sequences 
available at Genbank and rates them according to their similarity. A choice is made on the se-
quence with the highest specificity to our target to avoid non specific hybridization. Figure 3.2 is 
a BLAST analysis of B. anthracis lethal factor gene. Our choice and design of target is easy and 
any researcher can be able to use it. One can also use other search engine such as Entrez or 
ExPASy. Entrez allows users to search many discrete health sciences databases at the NCBI 
website. Entrez efficiently retrieve gene and protein sequences, structures and chromosomal 
maps. There also exist other probe design tools for designing optimal oligonucleotides such as 
OligoArray, OligoWiz, Array designer and Agilent eArrayv4.5 to name a few. This come in handy 
if one is dealing with a large number of probes. 
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Figure  3.2: BLAST alignment to check for specificity of B. anthracis RNA. 
 
3.3 Oligonucleotide probe design 
The design of probes is an important step due to the complex physicochemical con-
straints resulting from immobilization of probes on the chip surface. Highly selective and specific 
probes are required to attain high sensitivity. The probe should be long enough to be specific for 
a region of interest but not too long to introduce steric interactions especially when RNA is the 
target. RNA has the ability to form complex secondary structures which may interfere with hy-
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bridization.50a Other parameters to consider in probe design include base composition, se-
quence length and specificity. We have designed novel hybrid/chimera probes that allow direct 
detection of total RNA without prior enrichment, amplification, labeling and separation. The hy-
brid probes consists of three regions, i.e. 3’-DNA-2’-O-MeRNA-DNA (Figure 3.3). The probes 
are amino modified at the 3’- end to afford surface immobilization. 
Tethering one end of an oligonucleotide to a solid surface is expected to affect the kinet-
ics of duplex formation and other reactions in the solution. Various studies have shown tethering 
one end of an oligonucleotide probe to a microarray surface affects the accessibility of the oli-
gonucleotide near the surface than the one farthest away.50a The base nearest to the surface is 
less accessible than those further away. Due to steric constraints imposed by molecular interac-
tions on microarrays, a molecular spacer is normally introduced in the probe. The spacer sepa-
rates the hybridization region from the microarray surface thus reducing steric constraints intro-
duced which sometimes have a destabilizing effect on the chip surface. Hybridization yields 
have been shown to increase up to two orders of magnitude by introducing spacers.50a 106 
Guo et al. did extensive work to study the importance of a spacer by introducing a non-
specific poly dT spacer sequence at the end of the oligonucleotide immobilized on the surface.76 
They observed that experiments without spacers yielded no hybridization signals while inclusion 
of 6 or less poly dT yielded very low signal. But they observed an increase in signal with length 
up to 15 nucleotides. Poly or oligo (ethylene glycol) grafted surfaces have also been used as 
passivation layers to provide a variable distance between the surface and the oligonucleotides 
to avoid non-specific adsorption.64 107 The hydrophilic polymeric chains helps avoid steric hin-
drance in linker less DNA hybridization. This can also help resist the nonspecific adsorption of 
DNA on the chip surface. A dense PEG layer might also mask the inhomogeneities of the un-
derlying surface caused by inconsistent surface functionalization. A study in our laboratory con-
firms inclusion of a spacer yields higher signal. Normally we use 10-15 dNTPs which is part of 
the gene of interest. 
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The probes are designed to enable both RNase H and Klenow specificity. RNase H is an 
endonuclease capable of selectively digesting RNA in an RNA/DNA duplex. This is made possi-
ble by incorporating specific 2’-O-Me-methylyted RNA into the probes. The 2-O-methylated RNA 
probes were reported to have increased Tm, faster kinetics of hybridization and increased speci-
ficity against De-oxy probes.108 The methylated RNA component stabilizes the RNA probe 
against RNases.109 108 Finally, the last DNA portion enhances the performance of our probes on 
the microarray. This DNA portion serves both as a guiding sequence for RNase digestion and 
Klenow extension. The hybrid probes are amino alkylated at the 3’-terminus upon reaction with 
a commercially available amino modifier phosphoramidite derivative during solid phase synthe-
sis. 
 
Figure  3.3: B. anthracis hybrid probe with the three specific regions outlined. 
 
3.4 Microchip surface chemistry 
A high specific reaction and efficient coupling of probes is required due to drawbacks 
associated with microarray technology such as steric hindrance, non-specific interactions and 
inhomogeneous spot morphology.51 50a The substrates/microchips/chips are first silanized with 
aminopropyl trimethoxysilane. This is a fast and efficient silanization procedure to introduce 
amino group on the surface. Alkoxy silanes provide a surface with a myriad of straightforward 
synthesis solutions for further modification. Further funtionalization with homobifuntional cross 
linker 1, 4-phenylene diisothiocyanate (PDITC) introduces NHS groups that readily reacts with 
amino modified hybrid probes via N-hydroxylsuccinimide (NHS) displacement.76, 110 111 The 
bound probes are stable and can be kept for several months in -4 oC. Figure 3.4 illustrates the 
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procedure to obtain NSH chemistry on the glass or silicon surface. Prior to functionalization, 
glass microscope chips are usually activated by treatment with strong sulphuric acid to remove 
organic residues as well as hydroxylate the surfaces. 
The amino modified probes can also be immobilized on other surfaces such as alde-
hyde, epoxy or chinone surfaces.58 Aldehyde modification has been used in our lab with positive 
results even though the spot morphology was not well defined in comparison with phenylene 
diisothiocyanate surfaces. Also coupling on the aldehyde surface required longer times, up to 16 
hours compared with NHS displacement chemistry which takes 2 hours. Also post immobiliza-
tion reduction for the aldehyde modification was necessary to reduce background.51 52 
 
 
Figure  3.4: Activation of the silicon or glass chip surface. Surface chemistry enables im-
mobilization of amino modified sequences. 
 
3.5 Probe printing and immobilization 
Printing of the oligonucleotide was accomplished using a Cartesian Technologies robot 
with a stealth pin that deposited 0.7 nL/spot on the substrates. The sizes of the spots are ~75 
µm in diameter. The pins work by drawing probes into a small channel by capillary action like a 
fountain pen, also referred to as quilling. The microarray robotic system can accommodate 10 
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standard microscope slides with a capacity to operate 48 pins (Figure 3.5). One 384-well plate 
can be printed in ~7.5 minutes with over 100,000 features per slide. The pins are easy to handle 
and only require periodic cleaning using a buffer. In house printing is widely used in research 
laboratories because it is relatively cheap and easily modified to fit changing research problems. 
 
 
Figure  3.5: Omnigrid microarray robot and an SMP3 pin. 
 
3.5.1 3’-Labeling technique 
Our lab has developed a method that affords labeling and detection of mRNAs in an 
RNA mixture. Our system is based on RNA 3’-labeling approach where a DNA polymerase in-
corporates hapten labeled dNTPs directly on a DNA template immobilized on the chip 
surface.112 113 Upon hybridization, 3’-RNA portion hybridized to the DNA probe is digested by the 
RNase H. RNase H offers an advantage since it doesn’t digest RNA in an RNA duplex. This 
helps stabilize the RNA probe and the target RNA. The 2’-O-methylation of the RNA probe also 
stabilizes the probe RNA sequence against RNases.109 108 RNase H digestion exposes a DNA 
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template which acts as a guiding sequence for DNA polymerase labeling with biotin dNTPs 
(Figure 3.6). With this method, one or all the biotin labeled dNTPs can be used. The method 
allows specific labeling of the captured target RNAs at the 3’-end.103b Detection of specific RNAs 
in total RNA or in an RNA mixture is possible without separation, purification, reverse transcrip-
tion and PCR. The fact that short primers of up even 5 nucleotides can be used indicates the 
method can be used for short and degraded RNAs. The biotinylated probes are converted to 
enzymatic labels through the specific interaction of a binder enzyme conjugate. Further steps 
can afford desired detection methods i.e. radioactive, chemiluminescence, colorimetric or fluo-
rescence detection. 
 
 
 
Figure  3.6: Flow chart for the 3’-labelling principle 
3.6 Detection methods 
3.6.1 Radioactive detection 
Preliminary work to identify the right enzyme and the effectiveness of labeling was ac-
complished by use of radioactive detection. By labeling the target with α-32P dNTPs during 
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Klenow extension, radioactive detection was achieved even at the attomole level. The labeled 
nucleotides were also found to be stable.103b The method was used for specific detection of 
mRNA in a mixture of RNAs.114 While this method has high sensitivity, the radioactive probes 
are expensive with a short lifetime and the fact that they are toxic led to limited application. Ra-
dioactive labeling method has also not gained acceptance in microarray technology. 
3.6.2 Chemiluminescence detection 
Klenow extension with hapten labels e.g. biotin followed by enzyme conjugation will yield 
a chemiluminescent signal in the presence of a substrate. Enzymes such as horseradish perox-
idase and alkaline phosphatase are common reporter molecules for chemiluminescence detec-
tion. Alsaida et al., reported use of alkaline phosphate which yielded a chemiluminescent signal 
in the presence of dioxetane substrate.102 The main disadvantage with alkaline phosphatase 
catalyzed detection was longer exposure time (5h) which increased the background. Another 
option is to use HRP with streptavidin binding molecules. This is generally popular since HRP is 
less expensive than alkaline phosphatase and maximum intensity can be achieved in seconds. 
HRP detection has been demonstrated to the higher attomole level. 
3.6.3 Gold nanoparticles detection 
The recent advancement in AuNPs technology has led to development of diagnostics 
approaches which take advantage of the attractive physicochemical properties of the gold na-
noparticles. The nanoparticles can be easily fine tuned to afford different detection methods for 
example, electrochemistry and spectroscopy. AuNPs absorb and scatter light with extraordinary 
efficiency. Their strong interaction with light occurs because the conduction electrons on the 
metal surface undergo a collective oscillation when they are excited by light at specific wave-
lengths. This oscillation, known as a surface plasmon resonance (SPR), causes the absorption 
and scattering intensities of gold nanoparticles to be much higher than identically sized non-
plasmonic nanoparticles. AuNPS absorption and scattering properties can be tuned by control-
ling the particle size, shape, and the local refractive index near the particle surface. 
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3.6.4 Fluorescence detection 
Fluorescence detection, one of the most developed detection technique with the DNA 
microarray can also be applied on this RNA microchip. One way to generate signal is by use of 
Enzyme Labeled Fluorescence probes (ELF). The biotinylated targets are bound to streptavidin 
conjugated to alkaline phosphatase. Addition of an ELF substrate produces a fluorescent crystal 
that adheres to the slide surface by the action of alkaline phosphatase. The crystal can be ex-
cited by UV light upon which the emission is corrected using a wide pass filter. Use of a sec-
ondary antibody conjugated to a fluorophore will yield a fluorescent emission. Preliminary work 
with fluorescence detection was done using gold nanoparticles. 
3.7 Design, development and validation of RNA microchip 
Development of a rapid, sensitive accurate and cost-effective RNA chip is investigated. 
Our lab has developed a method that affords labeling and detection of mRNAs in an RNA mix-
ture. This method applied in cancer detection and pathogen detection. The method is direct and 
easy to use thus can easily be adapted as a POC devices or an easy to use micro fluidic sys-
tem. 
3.8 Experimental 
3.8.1 The hybrid probe synthesis and purification. 
The RNA probes were synthesized using standard solid phase phosphoramidite chemis-
try on ABI 3400 DNA synthesizer. The standard DNA phosphoramidites and commercial 2-O-
Me RNA phosphoramidites were purchased from Glen Research (www.glenresearch.com) and 
Azco Biotech (www.azcobiotech.com). The RNA probes were modified with amino groups at the 
3’-ends for immobilization on the chip surface. The RNA probes were deprotected in aqueous 
ammonium hydroxide solution (30%) at 55 oC overnight, followed by n-butanol precipitation. 
Then polyacrylamide gel electrophoresis (PAGE) was used to purify the RNA probes, followed 
by NaCl/ethanol precipitation. The quality of the probes was assessed by analytical PAGE, fol-
lowed by quantification with UV-Vis spectrophotometer. 
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3.8.2 Chip activation 
The glass chips (0.5 x 0.5 cm) were first degreased in CH2CL2 (Sigma Aldrich, St. Louis, 
MO) with gentle shaking for 30 min. The chips were subsequently cleaned in concentrated sul-
furic acid (Sigma Aldrich, St. Louis, MO) for 45 min with shaking. The chips were rinsed with de-
ionized water several times until the last wash had a pH 7. Silylation and amino activation was 
done by incubating the chips for 45 min with shaking in a mixture of 3% 3-
aminopropyltriemethoxysilane (APTS; Sigma Aldrich, St. Louis, MO) in aqueous ethanol (95% 
ethanol and 5% water). Once silylation was complete, the chips were washed three times, first 
with ethanol, water and a final rinse with ethanol and air dried. The activation to obtain amino-
reactive surfaces was accomplished by incubating the chips in a mixture of 1, 4-phenylene 
diisothiocyanate (PDITC; Sigma Aldrich, St. Louis, MO) and 1% pyridine (Fluca) in CH2Cl2 for 2 
hr. The chips were then washed three times in CH2Cl2 and air dried before storage at room 
temperature in a desiccator. A step-wise representation of the activation process is shown in 
Figure 3.4. 
3.8.3 Spotting and probe immobilization 
The synthesized hybrid probes were diluted to appropriate concentration using sodium 
phosphate buffer (100 mM, pH 8.5) followed by printing on the activated microchip using a Car-
tesian Technologies PixSys spotting robot (OmniGrid® Micro Digilab Inc, Holliston, MA) with a 
stealth pin that deposited 0.7 nL/spot on the substrates. The sizes of the spots were ~75 µm in 
diameter. The chips were then incubated in a water bath at 37 oC for 30 min for coupling. The 
aldehyde chips were incubated for 2 hours at 37 oC followed by 16 hours at room temperature. 
3.8.4 Imaging system: microscope, camera and imaging software. 
The imaging system consisted of a microscope (Nikon Eclipse 80i) equipped with an ul-
trasensitive charge coupled device camera (CCD, CXp-5500 XL, VersArray System; Princeton 
Instruments, Princeton, NJ) controlled by ImagePro Plus 6.1 computer software for image ac-
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quisition, processing and analysis (Media cybernetics, Inc., Silver Spring, MD). The detection is 
normally performed by using 2 x 2 images binning, 2X lens and an object distance of 1.5 cm. 
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4. CANCER BIOMARKERS DIRECT DETECTION ON THE RNA MICROCHIP 
 
4.1 Cancer biology 
Cancer is a major health problem in the United States and around the world resulting in 
over 7.6 million deaths per year. Cancer is a group of diseases characterized by uncontrollable 
growth and spread of abnormal cells. The transformation from a normal cell into a cancerous 
cell is a multistage process defined by three steps; initiation, promotion and progression. The 
initiation step is characterized by a permanent DNA mutation. Once the cell has been mutated 
by an initiator or a trigger, the mutated cell is susceptible to promotion. Promotion refers to the 
process of growth and proliferation of the mutated cells resulting in a small tumor which in the 
progression stage undergoes further transformation to a neoplasm and could potentially lead to 
malignancy. Sometimes progression may lead to metastasis when cancer cell acquires the abil-
ity to travel through the blood stream to other tissues of the organism. The transformation 
changes are a result of interaction between internal and external causative factors which may 
act together in sequence to initiate or promote cancer. Couple this with genetic differences 
among patients and the result is a disease characterized by great complexity and heterogenei-
ty.115 
4.2 Head and neck cancer 
Annually about 15,800 deaths are attributed to head and neck squamous cell carcinoma 
or referred to simply as head and neck cancer (HNSCC, HNC),116 making it the sixth most 
common form of cancer. HNC usually begins in the squamous cells that line the moist, mucosal 
surfaces inside the salivary glands of the head and neck. HNC therefore comprises of all tumors 
originating from the mucosa of the oral cavity, pharynx, larynx and cervical esophagus. The 
known risk factors include smoked and smokeless tobacco and excessive drinking of alcohol. 
Human papillomavirus (HPV) infection has also been linked with some types of HNSCC.117 118 
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In previous studies, gene expression profiles have shown correlations with tumor devel-
opment and progression.119 Therefore by monitoring gene expression, the altered gene patterns 
can be identified long before the physical characteristics are observable. These patterns offer a 
platform for the development of a molecular diagnostic tool for early detection of cancer. Analy-
sis of mRNA and microRNA in precancerous or cancer cells could afford a breakthrough in HNC 
detection and disease management.117a The goal of this research project is the search for a 
precise and early diagnosis method for early diagnosis of tumorous malignancies allowing for a 
tailored management of cancer. 
4.2.1 HNC biomarker detection 
A biomarker is any characteristic that can be objectively measured and evaluated as an 
indicator of the status of the normal biological processes and or pharmacologic responses to a 
therapeutic intervention.120 121 122 There are various sources of biomarkers such as body fluids, 
primary tissues and cell lines, surgical margin tissue and secondary tumors.118 Cancer status 
can be identified using different molecules i.e. DNA, RNA, proteins or metabolites of processes 
such as apoptosis, angiogenesis or proliferation. These also affords different diagnosis meth-
ods.118 121 123 122 The main goals of biomarker studies is to provide information for diagnosis, 
prognosis and therapeutics. An ideal biomarker should achieve all these goals which require 
extensive research and validation. 
The sources of biomarkers include the growth factors, angiogenic factors, cytokeratines, 
chemokines and matalloproteinases to name a few.124 125 126 127 While breast cancer has an in-
dependent biomarker for screening i.e. epidermal growth factor receptor (EGFR) or the recently 
approved 76 gene MammaPrint, there is no independent biomarker or profile for HNC.128 81 
Linkov et al., (2007) studied many factors such as hormones, proteases, growth and angiogen-
esis factors, cytokine, chemokines and adhesion molecules to identify biomarkers for a HNC 
multi-marker system using serum immune-based assays.129 From a panel of 60 biomarkers, 
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they identified 25 biomarkers with significant expression patterns between normal and cancer 
cells. From this panel, we selected three biomarkers for the development of a model HNC de-
tection RNA microchip. Among them were insulin-like growth factor binding protein 1(IGFBP1) 
and interleukin 8 (IL8) which were found to be higher in cancer groups than in normal cells.129 
Indeed, serum levels IL8 are consistently elevated in patients with HNC. Earlier studies by Li et 
al., showed that RNA isolated from cancer patients saliva had high levels of IL8.130 127 IL8 is also 
an important marker in other form of cancers i.e. ovarian, gastric, pancreatic, prostate, melano-
ma and colon cancer.131 132 
Recently, infectious diseases have been linked to causing cancer. Many infectious dis-
eases cause the body system to respond by causing inflammation. During a persistent infection, 
chronic inflammation can lead to continual damage and accumulation of genetic mutation. On 
the other hand, interaction of viruses with host DNA can lead to activation of genes that promote 
tumor growth. Of main importance are HPV and Epstein-Barr virus (EBV) viral infections which 
have been associated with several forms of cancers. HPV is a non-enveloped, circular DNA vi-
rus that has been implicated in a variety of diseases ranging from genital warts to cervical can-
cer.133 134 These viruses infect cells in the basal layer of squamos epithelium.135 HPV involve-
ment with HNC was first proposed in 1983 by Syrjanen et al and confirmed later by others.136 137 
Currently, more than 320 HPV types have been identified but the most important ones in HNC 
are HPV 16 and HPV 19.138 As a biomarker, HPV is becoming a major prognostic and predictive 
marker in HNC.118 HNC diagnostic will therefore greatly benefit from discrimination of HPV posi-
tive and HPV negative tumors (HPV+ and HPV- respectively). 
HPV tests include southern blot, in situ hybridization, immunostaining an immunohisto-
chemistry PCR and DNA microarray.139 140 Although PCR is a reliable and sensitive marker for 
HPV RNA and DNA detection, it cannot localize HPV to the area of neoplasia thus lowering the 
ability to distinguish clinically relevant HPV infection. In situ hybridization specificity is high and 
have commercially available kits with the Hybrid Capture 2 approved by FDA for pap smears but 
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application in HNC detection is limited due to the need to classify HPV positive and HPV-
negative tumors. It is therefore hypothesized that the RNA microchip can be used to distinguish 
between HPV+ and HPV- tumors. 
4.2.2 HNC markers target and probe design 
The target RNA should be gene specific to avoid non-specific hybridization. The probe 
should be long enough to be specific for a region of interest but not too long to introduce steric 
interactions especially when RNA is the target. RNA has the ability to form complex secondary 
structures. Other parameters to consider in probe design include base composition and se-
quence. Once the biomarkers were identified, a 40 nucleotide sequence of the genes was se-
lected from NCBI followed by BLAST search for sequence alignment for the three genes. 
Hybrid probes, DNA-RNA-DNA were thereby designed as complimentary sequence to 
the target. The probe had less the 10 nucleotides which compensated for the spacer. The RNA 
component consists of 15 2’-O-Me-methylyted RNA which has an important function in stabiliz-
es the RNA against RNases.109 108 Finally, the last portion of the probe consists of 15 dNTPs 
which acts as a guiding sequence for Klenow DNA polymerase incorporation with labels. 
4.2.3 Probe synthesis 
The hybrid probes were synthesized by solid phase phosphoramidite method on 3400 
DNA/RNA synthesizer (Applied Biosystems). Elution from the column was accomplished with 
30% NH4OH followed by incubation at 55 
oC for deprotection. The hybrid probes were purified 
by on an acrylamide preparative gel electrophoresis (PAGE) and eluted by soaking in water 
overnight. After ethanol/NaCl precipitation, the oligonucleotides were redissolved in water and 
concentrations determined spectrophometrically. The quality of the oligonucleotides was con-
firmed by use of analytical PAGE. Below is the oligonucleotide library for detection of HNC on 
the RNA microchip. 
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IGFBP1 RNA [Homo sapiens insulin-like growth factor binding protein 1 (IGFBP1), mRNA, 251-
290 nt]: 5’-GCAUCGGCCC CUGUCUGCUG CUCGCGCCUG-3’ 
IGFBP1 probe: 5’-d (CAGGCGCGAG CAGCA)-2’-O-Me-(GACAG GGGCCGAUGC) d 
(TCTCTGGGCT) - NH2-3’ 
VCAM1 RNA [Homo sapiens vascular cell adhesion molecule 1 (VCAM1), transcript variant 1, 
mRNA, 2051-2090 nt]: 5’-AUCUAUAGAU GGCGCCUAUA CCAUCCGAAA-3’ 
VCAM1 probe: 5’-d (TTTCGGATGG TATAG)-2’-O-Me-(GCGCC AUCUAUAGAU) d 
(TTTAGTACTG)-NH2-3’ 
IL8 RNA [Homo sapiens interleukin 8 (IL8), mRNA, 251-290 nt]: 5’-GUGAUUGAGA 
GUGGACCACA CUGCGCCAAC-3’ 
IL8 probe: 5’-d (GTTGGCGCAG TGTGG)-2’-O-Me-(UCCAC UCUCAAUCAC)-d 
(TCTCAGTTCA)-NH2-3’ 
4.3 3’-labeling strategy 
mRNA is mostly detected indirectly using cDNA coupled with PCR or RT-PCR. Signal 
detection therefore is time consuming and partially degraded RNA is not accounted for. Labeling 
a specific RNA in an RNA mixture is also difficult. Our lab has developed a method that affords 
direct labeling and detection of mRNAs in an RNA mixture. 102 103 The system is based on 3’-
labeling approach where a DNA polymerase incorporates hapten labeled dNTPs directly on a 
DNA template immobilized on a microchip.112 113 Before incorporation of the labels, the 3’-region 
is removed by RNase H in the presence of a guiding sequence. RNase H is an RNA endonu-
clease capable of selectively cutting RNA in an RNA/DNA duplex.141 108 Also, RNase H offers an 
advantage since it doesn’t digest RNA/RNA duplex. This prevents target RNA form digestion. 
The 2’-O-methylation of the RNA probe also stabilizes the probe RNA sequence against 
RNases.109 108 Once the biotin labeled dNTPs are incorporated by use of Klenow polymerase, 
they are converted to enzymatic labels through the specific interaction of a binder enzyme con-
jugate that catalyze chemiluminescent reactions in the presence of substrates (Figure 4.1). 
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Streptavidin-horseradish peroxidase binds specifically to the biotin labels and serves as 
an enzymatic label for the HNC mRNA. The bound horseradish peroxidase catalyzes an oxida-
tion-reduction reaction that produces chemiluminescence signal in the presence of enzymatic 
substrate. This signal can be detected using a CCD camera. Here we successfully demonstrate 
this approach by selective detection of HNC biomarkers (Figure 4.2). 
 
 
Figure  4.1: Flow chart for the rapid and direct RNA microchip. RNA (red) binds via com-
plimentary base pairing to the last two section of the hybrid probe. RNase H then digests 
the RNA portion of the RNA/DNA duplex. The resulting single stranded portion of the 
DNA acts as a guiding sequence for Klenow incorporation with biotin labeled dNTPs. 
Once streptavidin HRP binds to biotin, HRP enzyme interaction with substrate give the 
desired signal. 
 
4.4 Selectivity of the detection method 
Selectivity on the RNA microchip is critical to ensure accurate results are obtained. Se-
lectivity also helps in planning experiments to avoid wastage of time and precious samples. Re-
al samples or patient samples for research purposes can be difficult and costly to obtain so it is 
important to obtain accurate results when conducting microchip experiments. Selectivity is also 
important to check for viability as well as cross hybridization which will help avoid false positives 
that can be detrimental in human life. 
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4.4.1 Selectivity on the microchip 
First, selectivity assay was done by testing each RNA on the microchip. Four different 
chips were spotted with four different probes VCAM1, IGFBP1, IL8 and Avian flu (AF) respec-
tively (Figure 4.2). On each chip, a different RNA was applied. For example, on chip A, only 
VCAM1 RNA was applied while the other probes acted as negative control. As observed, there 
was no interference or cross hybridization from other mRNAs. 
The main challenge as observed in Figure 4.2 is signal consistency, for example IL8 on 
chip C had a strong signal compared to IGFBP1 on Chip B. The RNA chip needed for gene ex-
pression profiling requires a consistent signal transduction method for effective signal compari-
son. Such a method should also be able to report accurately the status of the cell without any 
bias. Optimization of experimental conditions on the RNA microchip was therefore needed to 
ensure similar signal transduction across all probes. A good comparison can only be made if 
signal transduction is the same. 
Hybridization is most efficient at 25 oC below Tm.
142 The GC content plays a major role in 
duplex strength with high GC percentage resulting in high Tm. As observed with the probes, 
IGFBP1 had a high GC content which would have increased the Tm. Hybridization at room tem-
perature must have compromised the signal due to the few hybrid duplexes formed. This tem-
perature must have been efficient for IL8 hybridization as observed with the slightly higher sig-
nal among the three. It is advised that the predicted Tm should be between 58-62 
oC for all 
probes to be used in one chip to ensure similar behaviour.143 Hybridization at higher tempera-
tures was therefore envisioned as a way to improve the signal (Table 4.1). Other changes in-
cluded increasing the time required for the enzyme-conjugate binging step. Previously washing 
was done with lots water which introduces variations if not well handled. But introduction of a 
PBS buffer washing step significantly reduced the background therefore improving signal to 
noise ratio (Figure 4.3). 
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4.4.2 Experimental 
Four different chips were printed with four probes; VCAM1, IGFBP1, IL8, and AF for se-
lectivity studies. After immobilization, the chips were incubated with StartingBlock blocking buff-
er for 20 min. Subsequently, each chip was flooded with a different RNA in 5x SSC buffer (20 
µL, 0.75M NaCl, 75 mM sodium citrate, pH 7.0) and incubated at room temperature for 15 min. 
The unbound RNAs were washed twice with 1x PBS buffer (137 mM NaCl, 2.7 mM KCl, 4.3 mM 
Na2HPO4, pH 7.4). The chips were then incubated with RNase H (0.5 µL, 5000 U mL/1) in 
RNase H buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, MA) at room temperature for 15 
minutes. The digested RNAs were then washed twice with 1x PBS buffer followed by polymer-
ase extension step with Klenow large fragment (0.5 µL, 5000 U mL/1) in Klenow buffer (20 µL, 
1x New England Biolabs® Inc, Ipswich, MA) and 1 µL of 0.4 mM biotin labeled dNTPs; biotin 
14-dATP (Invitrogen, Carlsbad, CA), biotin 14-dCTP (Invitrogen, Carlsbad, CA), biotin 11-dGTP 
(PerkinElmer, Waltham, MA) and biotin 11-dUPT (PerkinElmer, Waltham, MA). The chips were 
incubated at 37 oC for 30 minutes followed by washing (3 x) with PBS buffer. The chips were 
then incubated with Poly-HRP Streptavidin (Thermo Scientific, Rockford, IL) diluted 5000x in 
TBS buffer for 5 minutes. The chips were washed with a lot of water to remove unbound en-
zymes. SuperSignal ELISA Femto Maximum sensitivity substrates (Invitrogen, Carlsbad, CA) 
were applied on the chips. The chemiluminescence signal was captured with a CCD camera. 
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Figure 4Selectivity on the RNA microchip. The RNA chip was immobilized with similar 
probes, VCAM1, IGFBP1, IL8, and AF respectively. Only one RNA was applied on each 
chip i.e. VCAM1, IGFBP1, IL8, and AF on chips A, B, C and D respectively. 
 
Table  4.1: Condition optimization on the RNA microchip. Room temperature (RT) 
Step  Conditions  New Conditions  
Hybridization  RT 37 °C, Wash 3 x PBS buffer 
RNase H digestion  RT 37 °C, Wash 3 x PBS buffer 
Blocking  RT  37 °C 
Streptavidin HRP  Water Washing  Wash 5 x PBS buffer  
 
4.5 RNA microchip for multiple HNC biomarker identification 
Since there is no independent biomarker approved for HNC diagnosis, a microchip that 
allows for simultaneous detection of a number of biomarkers may present a promising approach 
for early diagnosis of HNC. The RNA chip can also be an important tool in the search of bi-
omarkers due to the unparalleled detection of many samples. Simultaneous detection enables 
one to get as much information relating to gene expression from one sample. A single hybridiza-
tion event in a microarray set up can help elucidate thousands of mRNA and thereafter help un-
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derstand many cell processes. In this way, identification of biomarkers and thereafter cancer 
detection is more simplified in comparison with RT-PCR where multiplexing is limited. Indeed a 
few markers are enough to give a disease status but only after they have been studied from a 
pool of markers and validated to give enough information that can aid in diagnostic and progno-
sis with a high confidential level. But since cancer is a result of many cellular processes gone 
berserk, it is hypothesized that a multi-marker detection will aid in elucidating and better under-
standing the processes. 
4.5.1 Simultaneous detection of HNC cancer biomarkers on the RNA microchip 
For simultaneous detection, five different chips were immobilized with BA, VCAM1, 
IGFBP1 and IL8 respectively (Figure 4.3). Chip A and B acted as positive control where only 
one target RNA was applied. On chip C, IGFBP1 and IL8 RNAs were applied while BA and 
VCAM1 acted as negative control. The RNAs applied on chips D and E are as indicated on the 
table below each chip. Figure 4.3 shows that the method is specific and simultaneous detection 
is possible with consistent results for different target RNAs. 
4.5.2 Experimental 
Five different chips were printed with four different probes; BA, VCAM1, IGFBP1, and IL8 
respectively. After immobilization step, the chips were incubated with StartingBlock (TBS, 
Pierce, Rockford, IL) blocking buffer for 20 min. The chips were then flooded with target RNA 
samples (500 fmol) in 5x SSC buffer (20 µL, 0.75M NaCl, 75 mM sodium citrate, pH 7.0) at 37 
oC for 15 min. The unbound RNAs were then washed (2x) with PBS buffer (137 mM NaCl, 2.7 
mM KCl, 4.3 mM Na2HPO4, pH 7.4). The chips were flooded with RNase H (0.5 µL, 5000 U 
mL/1) in RNase H buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, MA) followed by incu-
bation at 37 oC for 15 minutes. The digested RNAs were then washed (2 x) with 1x PBS buffer 
followed by incubation with Klenow fragment (0.5 µL, 5000 U mL/1) in Klenow buffer (20 µL, 1x 
New England Biolabs® Inc, Ipswich, MA) and biotin labeled dNTPS (1 µL, 0.4 mM); biotin 14 
dATP (Invitrogen, Carlsbad, CA), biotin 14-dCTP (Invitrogen, Carlsbad, CA), biotin 11-dGTP 
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(PerkinElmer, Waltham, MA) and biotin 11-dUPT (PerkinElmer, Waltham, MA) at 37 oC for 30 
minutes followed by washing (3 x) with PBS buffer. The chips were then incubated with Poly-
HRP Streptavidin (Thermo Scientific, Rockford, IL) diluted 5000x in TBS buffer for 15 minutes. 
The chips were rinsed with PBS buffer (5 x) to remove unbound enzymes. SuperSignal Elisa 
Femto Maximum sensitivity substrates (Invitrogen, Carlsbad, CA) were applied on each chip. 
The chemiluminescence signal was captured with a CCD camera. 
 
 
Chip A B C D E 
BA - - - - + 
VCAM1 + - - + + 
IGFBP1 - + + + + 
IL8 - - + + + 
 
Figure  4.2: Specificity and simultaneous detection of different RNAs. The chips were im-
mobilized with similar probes, BA, VCAM1, IGFBP1 and IL8 respectively. Different 
mRNAs were applied on the chips as shown on the table below each chip. (Positive sign 
indicates presence of the RNA (+); negative sign indicates absence of the RNA). (Positive 
(+); negative (-) 
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4.6 HNC cancer cell lines mRNA detection on the RNA microchip 
4.6.1 mRNA direct detection from head and neck cancer cell lines total RNA 
It has been shown that gene expression profiles between normal and cancer cells can 
be statistically different.75 124 127 Changes in the transcriptome have been shown to correlate 
with onset and progression of cancer with some genes over expressed while others are under 
regulated. This pattern can be identified by direct analysis of the transcriptome to identify which 
genes have been affected by the uncontrolled growth characteristic of cancer. Research target-
ing genes/mRNA as indicator of the cell status has opened new avenues not only in cancer di-
agnostics but also therapeutics where some of the identified genes have been marked as rele-
vant for drug targeting. As a matter of fact, mapping of the transcriptome have been used to di-
agnose cancer, identify the stage and predict the future trend.144 Several treatment options have 
been also developed to target some biomarkers.145 146 Biomarker studies therefore offer a wide 
array of benefits in cancer management. 
To test the effectiveness of the RNA microchip on real RNA, we used total RNAs ex-
tracted from different cancer cell lines i.e. TU 686, LN 686 and LN 212. The chips were printed 
with the three cancer probes; IL8, IGFBP1 and VCAM1. Initially, the total RNAs were first heat-
ed at 65 oC for 2 minutes and then hybridized on the surface with slow cooling at controlled hu-
midity. But method development and evaluation has shown treatment with NaOH at elevated 
temperatures give good and consistent results. The hybridization is also reduced to 3o minutes. 
The heating was necessary to disrupt any secondary structures that may interfere with target 
RNA duplex formation. Figure 4.4 is an indication that the RNA chip can be used to selectively 
and specifically detect mRNA from total RNAs. Selectivity and simultaneous detection was 
demonstrated by the ability to detect only the present RNAs which can be correlated to the 
mRNA expression level. TU 686 and LN 212 had two biomarkers detected i.e. IL8 and VCAM1 
while LN 686 had only VCAM1 detected. IGFB1 was not detected in any of the three cell lines. 
Even with the presence of thousands of mRNAs in thousands of nucleotides, there was no 
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cross hybridization among target RNAs as observed with different signal profiles. Specificity on 
the other hand was demonstrated by the fact that different cell lines showed different expression 
levels as observed on the chips. Discrimination at this level is a clear indication that the RNA 
microchip is specific to detect mRNA from different cell lines. 
The RNA microchip is sensitive enough to enable detection without RT-PCR, the ampli-
fication method used in DNA microarray experiments even when total RNA amounts is lower 
than the starting material in DNA microarray experiments (10 µg). The RNA microchip offers 
direct RNA detection which easily gives a direct status of the cell. The method is rapid since 
there is further treatment needed on the RNA after extraction. RT-PCR requires reverse tran-
scription and thereafter PCR amplification. These steps can be time consuming and often are 
marred by contamination. In addition, high hybridization yields were achieved even at short hy-
bridization time in comparison to the DNA microarray which are normally done at longer hybridi-
zation times (16 hrs for hybridization step only). 
4.6.2 Experimental 
The cell lines total RNA was prepared at Emory University. Four different chips were 
immobilized with three different probes; IL8, IGFBP1 and VCAM1 respectively. After immobiliza-
tion step, the chips were incubated with StartingBlock (TBS, Pierce, Rockford, IL) blocking buff-
er for 20 min. Chip A was flooded with synthetic RNA samples in 5x SSC buffer (20 µL, 0.75M 
NaCl, 75 mM sodium citrate, pH 7.0) and incubated at 37 oC for 15 min. The cancer cell lines 
total RNA was heated for 5 minutes at 92 °C in NaOH, neutralized, added to 5x SSC and ap-
plied the remaining chips and incubated at 37 °C for 30 minutes. The unbound RNAs were then 
washed (2 x) with PBS buffer (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, pH 7.4). The chips 
were then flooded with RNase H (0.5 µL, 5000 U mL/1) in RNase H buffer (20 µL, 1x New Eng-
land Biolabs® Inc, Ipswich, MA) followed by incubation at 37 °C for 15 minutes The digested 
RNAs were then washed (2 x) with PBS buffer followed with incubation with Klenow fragment 
(0.5 µL, 5000 U mL/1) in Klenow buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, MA) and 
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biotin labeled dNTPS (1 µL, 0.4 mM); biotin 14-dATP (Invitrogen, Carlsbad, CA), biotin 14-dCTP 
(Invitrogen, Carlsbad, CA), biotin 11-dGTP (PerkinElmer, Waltham, MA) and biotin 11-dUPT 
(PerkinElmer, Waltham, MA) at 37 oC for 30 minutes followed by washing (3 x) with PBS buffer. 
The chips were then incubated with Poly-HRP streptavidin (Thermo Scientific, Rockford, IL) di-
luted 5000x in TBS buffer for 15 minutes. The chips were rinsed five times with PBS buffer to 
remove unbound enzyme. SuperSignal Elisa Femto Maximum sensitivity substrates (Invitrogen, 
Carlsbad, CA) were applied on each chip. The chemiluminescence signal was captured with a 
CCD camera. 
 
Chip A B C D 
Cell lines - TU 686 LN 686 LN 212 
IL8 + + - + 
IGFBP1 + - - - 
VCAM + + + + 
 
Figure  4.3: Detection of mRNAs in total RNAs from different HNC cancer cell lines. The 
chips were immobilized with similar probes, i.e. IL8, IGFBP1 and VCAM1 respectively. 
Chip A acted as positive control while on chip B and C had 4.4 µg of RNA applied while 
2.2 µg of total RNA was applied on chip D. The detected biomarker is as indicated below 
each chip. 
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4.7 Human papilloma virus as a marker for head and neck cancer 
4.7.1 HPV related cell lines mRNA detection on the microchip 
HPV-related head and neck cancers occur primarily in the oropharynx (tonsils and the 
back of the tongue). Oropharyngeal cancers are more common in white men. Researchers be-
lieve that up to 80% of oropharyngeal cancers in the U.S. are due to infection with the HPV vi-
rus. HPV is therefore an important HNC marker and its detection will help understand it is role 
and implication in cancer progression. In this case study, two different sets of cancer cells lines, 
set 1 with HPV+ DNA and set 2 with HPV- DNA were hypothesized to have different biomarker 
expression. 
The relevance of HPV infection on the cancer cell lines was studied using our markers 
on our novel RNA microchip. The chips were immobilized with different markers, i.e. IL8, 
IGFBP1 and VCAM1 (Figure 4.5). Chip A and B acted as positive controls while on chips C and 
D, two different cell lines i.e. SSC90 (HPV positive) and M4-GFP (HPV negative) applied on 
them respectively. Selectivity was highly achieved on the chips as observed with different levels 
of expression levels for the biomarkers. Specific is clearly demonstrated by the difference in the 
expression levels of the two cell lines. M4-GFP had higher expression of IL8 compared with 
SSC90. Also, there is a trace IGFP1 signal for M4-GFP on chip D. This is the first time IGFP1 is 
selectively detected from the cell lines, even though the signal is marred by artifacts. Even 
though we are dealing with only one sample comparison, these results combined with other bi-
omarkers results are a clear indication that the RNA microchip can be used for expression profil-
ing studies. 
4.7.2 Experimental 
The HPV cancer cell lines total RNAs were prepared at Emory University. Four different 
chips were immobilized with three different probes; IL8, IGFBP1 and VCAM1 respectively. After 
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immobilization step, the chips were incubated with StartingBlock (TBS, Pierce, Rockford, IL) 
blocking buffer for 20 min. Chip A and B were flooded with synthetic RNA samples in 5x SSC 
buffer (20 µL, 0.75M NaCl, 75 mM sodium citrate, pH 7.0) and incubated at 37 oC for 15 min. 
The HPV cancer cell lines total RNA was fragmented with 50 mM NaOH solution by heating for 
5 minutes at 92 °C. The fragmented RNA samples were cooled down in ice, centrifuged and 
neutralized using 1N acetic acid. Hybridization buffer was added to the fragmented RNA, ap-
plied on the remaining chips and incubated at 37 °C for 30 minutes. The unbound RNAs were 
then washed (2x) with PBS buffer (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, pH 7.4). The 
chips were then flooded with RNase H (0.5 µL, 5000 U mL/1) in RNase H buffer (20 µL, 1x New 
England Biolabs® Inc, Ipswich, MA) followed by incubation at 37 oC for 15 minutes The digested 
RNAs were then washed (2 x) with PBS buffer followed by incubation with Klenow fragment (0.5 
µL, 5000 U mL/1) in Klenow buffer (20 µL, 1x New England Biolabs, MA) and biotin labeled 
dNTPS (1 µL, 0.4 mM); biotin 14-dATP (Invitrogen, Carlsbad, CA), biotin 14-dCTP (Invitrogen, 
Carlsbad, CA), biotin 11-dGTP (PerkinElmer, Waltham, MA) and biotin 11-dUPT (PerkinElmer, 
Waltham, MA) at 37 oC for 30 minutes followed by washing (3 x) with PBS buffer. The chips 
were then incubated with Poly-HRP Streptavidin (Thermo Scientific, Rockford, IL) diluted 5000x 
in TBS buffer for 15 minutes. The chips were thereafter rinsed five times with PBS buffer to re-
move unbound enzyme. SuperSignal Elisa Femto Maximum sensitivity substrates (Invitrogen, 
Carlsbad, CA) were applied on each chip. The chemiluminescence signal was captured with a 
CCD camera. 
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Chip A B C D 
Cell lines - - SSC 90 
M4-
GFP 
   
HPV+ HPV- 
IL8 + + + + 
IGFBP1 + + - - 
VCAM + + + + 
 
Figure  4.4: Detection of mRNAs in total RNAs from HPV related cancer cell lines. The 
chips were immobilized with similar probes, i.e. IL8, IGFBP1 and VCAM1 respectively. 
Chip A and B had synthetic RNAs applied. Chip A had IL8 and IGFBP1 applied to it while 
VCAM1 acted as negative control. Chip B had all RNAs applied. On chip C, 2.75 µL of 
SSC 90 (2.42 µg), HPV positive cell line was applied and chip D had 2 µL M4-GFP (3.32 
µg), a HPV negative cell line applied. The detected signal is as indicated in the table be-
low each chip. 
 
4.8 Human colon cancer 
4.8.1 Introduction 
Colorectal cancer, commonly known as colon cancer or bowel cancer, is a cancer from 
uncontrolled cell growth in the colon or rectum (parts of the large intestine) or in the appendix. 
Colon cancer is the fourth most common type of cancer in Western society.115 Symptoms of col-
orectal cancer typically include rectal bleeding and anemia which are sometimes associated 
with weight loss and changes in bowel habits. Colon cancer collerates strongly with genetic al-
58 
terations that occur during the progression from adenoma to carcinoma to metastatic disease.147 
148 149 Molecular diagnostics therefore offer the promise of precise and systematic cancer diag-
nostics and classification but current marker and molecular diagnostic methods are not recom-
mended for clinical use due to diversity of results among different platforms.149 There is there-
fore ongoing research to better molecular diagnostics methods for better performance in cancer 
diagnostics. It was therefore hypothesized that the RNA microchip can be used as a tool for 
human RNA detection on the chip. Even though the method was designed for HNC markers, 
there is a tendency for markers to be over expressed in different cancers especially because 
they have a unique common role in the body. As stated earlier, some cancer biomarkers play an 
important role in more than one cancer. IL8 a chemokine, has been detected in many human 
tumors including colorectal cancer.150 151 In addition, the behavior of RNAs should be the similar 
if present in the colon tumor. 
4.8.2 Detection of human colon cancer mRNA on the RNA microchip 
Detection of real RNAs from colon cancer was evaluated on the RNA microchip. Figure 
4.6 is an indication that the microchip can be used to detect mRNAs from human total RNAs. 
Chip A acted as a positive control while others were test controls from different batches of colon 
samples. As observed, VCAM1 and IL8 were detected on chip B while only VCAM1 was detect-
ed on the other chips. Not surprising because biomarker studies on colon cancer have reported 
higher VCAM levels in cancer patients.152 Detection of the two mRNAs in a mixture of thousands 
of genes without separation or RT-PCR is a promising result for the RNA microchip. Different 
total RNAs were applied on the chip due to the availability but even at 1.4 µg the signal is strong 
enough for chip A. Also different expression levels can be observed among the batches which is 
an indication the of the microchip exceptional specificity. 
4.8.3 Experimental 
The colon cancer total RNA samples were provided by Georgia Health Sciences Univer-
sity. Four different chips were immobilized with three different probes; VCAM1, IL8 and IGFBP1 
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respectively. After immobilization step, the chips were incubated with StartingBlock (TBS, 
Pierce, Rockford, IL) blocking buffer for 20 min. Chip A was flooded with synthetic RNA samples 
in 5x SSC buffer (500 fmol, 20 µL, 0.75M NaCl, 75 mM sodium citrate, pH 7.0) and incubated at 
37 oC for 15 min. The colon cancer total RNAs were fragmented by heating for 5 minutes at 92 
oC. The fragmented RNA samples were cooled down in ice, centrifuged for 30 seconds, diluted 
in 5x SSC buffer and applied on the remaining chips. The chips were incubated for 30 minutes 
at 37 oC. The unbound RNAs were then washed (2 x) with PBS buffer (137 mM NaCl, 2.7 mM 
KCl, 4.3 mM Na2HPO4, pH 7.4). The chips were then flooded with RNase H (0.5 µL, 5000 U 
mL/1) in RNase H buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, MA) followed by incu-
bation at 37 °C for 15 minutes The digested RNAs were then washed with PBS (2x) buffer fol-
lowed by incubation with Klenow fragment (0.5 µL, 5000 U mL/1) in Klenow buffer (20 µL, 1x 
New England Biolabs® Inc, Ipswich, MA) and biotin labeled dNTPS (1 µL, 0.4 mM); biotin 14-
dATP (Invitrogen, Carlsbad, CA), biotin 14-dCTP (Invitrogen, Carlsbad, CA), biotin 11-dGTP 
(PerkinElmer, Waltham, MA) and biotin 11-dUPT (PerkinElmer, Waltham, MA) at 37 oC for 30 
minutes followed by washing with PBS buffer (3 x). The chips were then incubated with Poly-
HRP Streptavidin (Thermo Scientific, Rockford, IL) diluted 5000x in TBS buffer for 15 minutes. 
The chips were rinsed five times with PBS buffer to remove unbound enzyme. SuperSignal Eli-
sa Femto Maximum sensitivity substrates (Invitrogen, Carlsbad, CA) were applied on each chip. 
The chemiluminescence signal was captured with a CCD camera. 
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Chip A B C D 
Colon tumor - Batch 1 Batch 2 Batch 3 
VCAM1 + + + + 
IL8 + + - - 
IGFBP1 + - - - 
 
Figure  4.5: Detection of mRNAs in colon tumor total RNAs. The chips were immobilized 
with similar probes, VCAM1, IL8 and IGFBP1 respectively. Chip A acted as a positive con-
trol while different amount of colon tumor RNA from different batches were applied on 
the other chips. Chip B had 1.4 µg of colon RNA, chip C, 1.4 µg and Chip C had 2.2 µg re-
spectively. The detected marker is as indicated below each chip. 
 
4.9 Summary 
A rapid, selective, specific and sensitive RNA microchip was demonstrated. High selec-
tivity was observed with short synthetic RNAs which gave us the confidence to test total RNAs 
extracted from cancer cell lines. Detection of head and neck cancer total RNAs non specific 
cancer cell lines and HPV related cell lines on the RNA microchip was reported. The RNA mi-
crochip had high selectivity and specificity for the biomarkers selected. Results show a repeata-
ble specific signature from the total RNA which is an indication that there was no cross hybridi-
zation or nonspecific interaction even when we target only a few mRNAs i.e. VCAM1, 1L8, and 
IGFBP1 from a mixture of thousands of RNA. 3’-labelling technique enabled selective and spe-
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cific detection of only the three markers and only if present in the system. This was accom-
plished without prior extraction of mRNAs or selection using primers, reverse transcription and 
amplification as commonly observed with DNA microarrays. The method is highly sensitive as 
observed with the low amount of starting material (5 µg) in comparison with RT-PCR recom-
mended starting material (10 µg) for DNA microarray experiments. 
The different signal intensity observed with HPV related cell lines as well as other cell 
lines suggest that the RNA microchip can also be used as reporter for gene expression profiling. 
By using the RNA microchip, we are also able to detect the cancer mRNA from human colon 
cancer total RNA without amplification or prior mRNA extraction. The RNA probes are highly 
specific to capture the targeted sequence if present. The performance of the few genes indicate 
no requirement of other mismatched probes as observed with Affymetric system due to high 
level of cross hybridization on their chips even though the size of probes is the same. This direct 
RNA microchip is simple with minimal step and thus is well adaptable for a POC device. 
Development of a rapid, sensitive accurate and cost-effective RNA chip for early detec-
tion of HNC is reported. A breakthrough in this field will also find other applications in drug de-
velopment, efficacy optimization and toxicity analysis. It is important to note that even with dif-
ferent mRNAs in the cell lines, it was possible to detect the three RNAs simultaneously without 
any visible interference or cross hybridization. Application of the RNA chip on different cancers 
is an indication for application as a universal tool for expression profiling as well as cancer diag-
nosis. The RNA microchip is a good candidate for the detection of any kind of RNA, i.e. mRNA, 
small RNAs, rRNAs or microRNAs as long as specific probes are designed. The length of the 
RNAs is also not a limitation as fragmentation experiments will denature secondary structures. 
Upon hybridization, RNase H will digest all other RNAs thus enhancing the performance of other 
subsequent steps. The method is easy, rapid, specific and quite sensitive. 
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5. NOVEL RNA MICROCHIP FOR RAPID AND DIRECT DETECTION OF PATHOGENIC 
BACTERIA 
 
5.1. Introduction 
Pathogen identification and detection is an important part of research in many fields e.g. 
food safety, water safety, animal health care, pathology, diagnostics, forensics and biodefense. 
Of great importance is food borne illnesses arising from improper handling of food during prepa-
ration and storage which are becoming a major challenge to human survival. Man seems help-
less against these unpredictable epidemics even with constant preventive and control 
measures. One of the main causative agents of food borne infections diseases includes patho-
genic E. coli, salmonella and Campylobacter jejuni. Although most E. coli bacteria are important 
component of the biosphere and are harmless, others are notorious for causing food borne in-
fections. Pathogenic E. coli strains are responsible for infections of the enteric, urinary, pulmo-
nary and nervous systems. For example, the shiga toxin producing E. coli (STEC) is responsible 
for food-borne outbreaks from contaminated food or water. The strain O157:H7 of E. coli is con-
sidered one of the most dangerous food-borne pathogens and has been associated with several 
outbreaks.153 154 155 
Current methods rely upon conventional clinical microbiology monitoring which suffer 
considerable drawbacks. Indeed the most sensitive and reliable method is the detection of en-
dotoxins via coagulation of horseshoe crab blood using the limulus amebocyte lysate (LAL).156 
157 But the standard culture and susceptible test are laborious, time consuming and expensive 
and are plagued by many interferences. Besides, the methods do not characterize the virulence 
factors and can only handle a small set of samples at a time. 
There is therefore a need for reliable and accurate tools for pathogen detection. Molecu-
lar diagnostics is one of the most attractive areas since one can determine the pathogen, viru-
lence, and serotypes by taking advantage of the unique genomic signature (DNA or RNA) for 
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each organism. Advances in this field have been made possible by the availability of genomic 
information. Invention of PCR and thereafter qPCR was seen as a major breakthrough in mi-
crobe detection but reverse transcription inclusion not only increases detection time but also 
errors could be amplified in the process. DNA microarrays are able to combine the powerful 
amplification strategies with the multiplex screening resulting in high sensitivity and throughput. 
But they are limited by the cost and the organizational complexity of performing large number of 
PCR. This indirect measurement requires a further validation step which among other afore-
mentioned problems has reduced the utility of this technique. There is therefore an ongoing 
search for a rapid and sensitive method for pathogenic detection. 
To meet this challenge, our lab has developed a method for direct RNA detection on a 
microchip. The RNA microchip affords a direct and sensitive method for detection of E. coli total 
RNA without reverse transcription and thereafter PCR amplification. Further, we have devel-
oped a very fast, simple and reliable method for direct extraction of total RNA using NaOH. By 
treating bacteria cells directly using NaOH to extract RNA, we are able to detect lacZ mRNA di-
rectly from the supernatant. Direct extraction of total RNA and detection on the RNA chip over-
rides the long RNA purification process using kits. This not only reduces operation cost but also 
the RNA handling time. The RNA chip is a good POC diagnostic candidate for E. coli monitoring 
and detection in food and recreational water pathogens as well as any other field that require 
RNA detection. 
5.2. Hybrid probe design 
Probe design is an important aspect in a microarray experiment. This will ensure selec-
tivity, hybridization specificity as well as sensitivity. We adapted the hybrid probes as discussed 
in chapter 3. The hybrid probes have three regions as mentioned but in this case, the target 
RNA was chosen from a genome region with multiple Ts. This allows incorporation of biotin 
dATP as the only hapten label. Three different probes lacZ probes were designed with a con-
secutively shorter 2-O-Me RNA (Figure 5.1). The behavior of the probes was tested on the chip. 
64 
The experimental assay was as outlined in chapter 3. The 3’-labelling principle can be 
applied to any RNA by designing specific probes. As shown in Figure 5.1, probe with 10 nucleo-
tides in the region gave a higher signal followed by 15 nucleotides. It can be observed that a 
probe as short as 5 nucleotides is enough to stabilize the region and or anchor the RNase H. 
this is an indication that as short as 5 nt probes can be detected on the chip. This method can 
therefore be applied for degraded RNAs. The signal was slightly lower than the other probes 
due to the hybridization competition but on its own, 5M probe gives a strong signal. 
Even though 10M gave the highest signal, further experiments using total RNA extracted 
from E. coli had non-specific hybridization with 10M which led to the use of 35.1 (lacZ) probe. 
This study will enable better design of probes in future to give the highest hybridization yields. 
Below are the lacZ hybrid probes which target the same RNA. The naming is derived from the 
shorter 2’-O-Me-RNA region except for the 35.1 probe. 
 
lacZ mRNA (lacZ, E. coli lacZ mRNA: 724-748 nt): 5’-AUGUGGAUUGGCGAUAAAAAACAA-3’ 
35.1 probe: 5’-d (GTTGTTTTTT)-2’-O-Me-RNA (AUCGCCAAUCCACAU)-d (CTGTGAAAGA)-NH2-3’ 
10M probe: 5’-d (GTTGTTTTTT)-2’-O-Me-RNA (AUCGCCAAUC)-d (CTGTGAAAGA)-NH2-3’ 
5M probe: 5’-d (GTTGTTTTTT)-2’-O-Me-RNA (AUCGC)-d (CTGTGAAAGA)-NH2-3’ 
 
5.2.1 Experimental 
The chip was spotted with three lacZ probes; 35.1, 10M and 5M. After immobilization, 
the chips were incubated with StartingBlock TBS blocking buffer for 20 min. Subsequently, the 
chip was flooded with a 500 fmol RNA in 5x SSC buffer (20 µL, 0.75M NaCl, 75 mM sodium cit-
rate, pH 7.0) and incubated at 37 oC for 15 min. The unbound RNAs were washed twice with 
PBS buffer (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, pH 7.4). The chips were then incu-
bated with RNase H (0.5 µL, 5000 U mL/1) in RNase H buffer 20 µL, 1x New England Biolabs® 
Inc, Ipswich, MA) followed by incubation at 37 oC for 15 minutes. The digested RNAs were then 
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washed twice with PBS buffer followed by incubation with Klenow large fragment (0.5 µL, 5000 
U mL/1) in Klenow buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, MA) and 1 µL of 0.4 
mM; biotin labeled 14-dATP (Invitrogen, Carlsbad, CA). The chip was incubated at 37 oC for 30 
minutes followed by washing three times with 1x PBS buffer. The chips were then incubated 
with Poly-HRP Streptavidin (Thermo Scientific, Rockford, IL) diluted 5000x in TBS buffer for 15 
minutes followed by washing 5x with PBS to remove unbound enzymes. SuperSignal ELISA 
Femto Maximum sensitivity substrate (Invitrogen, Carlsbad, CA) was applied on the chips and 
the chemiluminescence signal captured immediately with a CCD camera. 
 
Figure 5.1: Probe design specificity results. The chip was immobilized with 3 different 
lacZ probes i.e. 35.1, 10M and 5M respectively. lacZ RNA was applied to the chip. 
 
5.3. E. coli cells generation 
The wild type strain (MG1655) approximates wild-type E. coli but with only minimal ge-
netic manipulation.158 The wild type lac operon has two distinct mechanisms of regulation; one 
stimulates transcription and the other down-regulates transcription. Inducers of lac operon i.e. 
isopropyl β-D-1-thiogalactopyranoside (IPTG) permit transcription by binding to lac repressor. 
This process is also controlled by the presence of cyclic AMP and its receptor protein which 
binds to the lac promoter thus stimulating transcription. The cAMP levels are strongly influenced 
by the amount of carbon in the medium. Addition of glucose as a source of carbon therefore 
leads to low cAMP which consequently leads to low transcription level. By using these two 
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agents, we are able to generate both lacZ induced and lacZ repressed cells which acts as a 
positive and negative control in the experimental system.159 160 
The bacteria strain; an E. coli K-12 MG1655 was a gift from Scarab Genomics LLC 
(Madison, WI). Growth of MG1655 on LB medium was previously reported to give good results. 
Generation of the bacteria was done by first inoculating on the plate or directly on a starter cul-
ture. In our experiments, inoculation was done directly in the starter culture. Streaking on the 
plate was only considered as a control method. Initially, growth was monitored by UV spectro-
photometer with induction done at OD 600 of at least 0.6. This was generally achieved after 
~2.30 hrs thus requiring only OD periodic measurements. Different induction timings were test-
ed with 6 hours giving the best results on the chip. Four hours induction time was probably too 
short as the signal on the chip was very weak while more than 6 hrs did not improve the signal. 
Different bacteria dilution ratio was also tested with 1:50 giving the best results. 
5.3.1 Experimental; E. coli cell preparation 
The cells (5 µL) of the wild-type E. coli bacteria strain (K-12 MG1655) culture (or a colo-
ny) were used to inoculate 6 mL Luria Broth (LB, Sigma Aldrich, St. Louis, MO) and the culture 
was incubated overnight at 37 oC with shaking at 220 RPM. The bacteria culture was then add-
ed to a 1L-Erlenmeyer flask containing 300 mL of sterilized LB culture and incubated for 2.5 hr 
at 37 oC. The culture was equally divided, followed by adding isopropyl β-D-1-
thiogalactopyranoside (IPTG, Sigma Aldrich, St. Louis, MO) to one portion (final concentration: 
1 mM; inducing LacZ mRNA expression) and adding D-(+)-glucose (Sigma, St Louis, MO) to the 
other flask (final concentration: 1 mM; suppressing LacZ mRNA expression). Both cultures were 
incubated for additional 6 hr at 37 °C. The E. coli cells were then harvested by centrifugation. 
Total RNAs of E. coli cells were extracted and purified using MasterPure Complete RNA Purifi-
cation Kit (Epicenter Biotechnologies Madison, WI). The final RNA samples were dissolved in 
-HCl (pH 7.5), 1mM EDTA]. The quantities of the IPTG-induced 
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and glucose-suppressed total RNAs were determined by UV-Visible spectrophotometer (Varian 
Inc., Sana Clara, CA). 
5.4. Target RNA extraction and purification 
Proper RNA detection is preceded by RNA extraction process. This step must be han-
dled with a lot of caution due to the sensitive nature of RNAs. There are several procedures for 
RNA extraction depending on the source of the RNA. Bacteria do not have poly-A tail therefore 
it is difficult to separate mRNAs from the total RNA. On the other hand, total RNA requires less 
handling and even works better therefore there is usually no need for mRNA isolation proce-
dures unless need be. Traditional RNA extraction protocol involves use of phenol/chloroform 
extraction which has been criticized due to the use of potentially dangerous procedure and its 
laborous.42 161 162 A variety of total RNA purification kit are commercially available from different 
commercial sources i.e. Invitrogen, Qiagen, Ambion and TRIzol which is based on phenol ex-
traction method. 
The RNA from both IPTG-induced and glucose-suppressed E. coli cells was extracted 
using the MasterPure RNA Purification protocol. The salt based-RNA extraction protocol effec-
tively removes proteins including enzymes. Removal of DNA by RNase-free DNase 1 not only 
increases sensitivity but also helps reduce nonspecific binding and background. Total RNA is 
precipitated using isopropanol with a final rinsing done with ethanol (2 x). The RNA is dissolved 
in TE buffer followed by UV measurement to determine the concentration and purity. Purity was 
determined by calculating 260/280 with a ratio of 2 considered to be pure RNA. High purity RNA 
was required in these experiments with a value <1.9 affecting the signal. Further purification of 
lower ratio RNA was done using phenol-chloroform extraction but this did not improve the purity 
of the RNA. 
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5.4.1 Experimental; total RNA extraction and purification from E. coli cells 
Total RNA of E. coli cells was extracted and purified according to MasterPure Complete 
RNA Purification kit with some modifications (Epicenter Biotechnologies Madison, WI). After pu-
rification, the purity and concentration of the total RNA were determined by measuring absorb-
ance using UV-Visible spectrophotometer (Varian Inc., Sana Clara, CA). The RNA was dis-
solved in TE buffer (10mM Tris-HCl [pH 7.5], 1mM EDTA) and stored in -80 oC. 
5.5. Detection of lacZ RNA from E. coli total RNA. 
Detection of specific RNAs from total RNA presents a number of challenges. For one, 
the RNAs tend to be long and have ability to form secondary structures and tertiary structures. 
This may hinder efficient probe-target duplex formation especially because microarray experi-
ments use shorter probes. This may lead to reduced hybridization efficiencies and therefore low 
signals. Proper measures are therefore required to reduce the size of the RNA as well as the 
intrinsic secondary structures. One method to accomplish this is by fragmentation of RNAs to 
shorter sequences which has been shown to improve hybridization signals. Fragmentation can 
often be done via chemical, enzymatic or thermal mediation.163 164 165 
Secondly, it is not easy to label specific RNAs in an RNA mixture. This led to increased 
use of DNA microarrays which normally use transcribed and amplified RNA either as cRNA or 
cDNA. We therefore present a method for detection of mRNA from total RNA without reverse 
transcription. In our experimental procedure, we are able to label specific RNAs, only the ones 
captured by our specific probes. This is made possible by internal hydrolysis of all non hybrid-
ized RNAs using RNase H. Also, RNase H digests RNA/DNA duplex thus exposing the Klenow 
guiding sequence which enables internal labeling of the target RNA. In this way, we are able to 
directly label and detect mRNA in a total RNA mixture without amplification. 
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5.6  Alkali assisted fragmentation of E. coli total RNA 
The covalent backbone of RNA is subject to slow, nonenzymatic hydrolysis of the 
phosphodiester bonds to yield a mixture 2’- and 3’-nucleoside monophosphates. This also leads 
to reduction in size into shorter, less structured fragments which can easily be available for hy-
bridization. Hydrolysis can be mediated by bases which help cut the RNA into small fragments. 
Liu et al., found that heating rRNA with NaOH produced 20-100 shorter RNA which improved 
hybridization efficiency on the microarray.163 
In an effort to improve sensitivity, optimization of the fragmentation parameters was nec-
essary. The chips were immobilized with three different probes; negative control (BF), lacZ and 
positive control (BA, 25 fmol). For each of the concentration, four different time variations were 
done to determine the best fragmentation condition time with the temperature held at 92 oC. The 
NaOH assisted hydrolysis of total RNA improved the signal as shown on Figure 5.2. Thermal 
denaturation alone did not have any signal (Chip A). While 20 mM NaOH had low signal except 
at longer timings, 100 mM NaOH was marred with a lot of background with a positive signal only 
observed at 5 min fragmentation. 50 mM NaOH was the best overall fragmentation concentra-
tion with a signal observed in all timings, i.e. 1, 5, 7 and 10 minutes. It was observed that 5 min 
gave a significantly better signal in all the three NaOH concentrations. Next, 5 min fragmenta-
tion time was tested for all the condition in one set-up to identify the best concentration using 30 
µg total RNA (Figure 5.2). Chip A (0 mM) and chip B (20 mM) had barely any signal while chip D 
(100 mM) had a lot of background to a point where the blocking effect of the spotted probes can 
be observed. Also, this condition did not afford a consistent signal. Chip C which was treated 
with 50 mM NaOH had the best signal compared to the others and the signal was consistent 
too. Therefore, this concentration was chosen for other experiments. This concentration has 
been reported in literature but at lower temperature and longer timings. 
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5.6.1  Experimental 
The chips were immobilized with three different probes; BF probe, lacZ probe and BA 
probe. RNA fragmentation was carried out by either heating in absence or presence of NaOH. 
For alkaline-catalyzed fragmentation, 10 µL of RNA (30 µg) of total RNA was digested with dif-
ferent concentrations of sodium hydroxide (NaOH) at 92 oC, Chip A sample was only heated in 
TE buffer, B; 20 mM NaOH, C; 50 mM NaOH and D; 100 mM NaOH. Heating was accom-
plished at 92 oC for 5 minutes. Previous experiments had involved different time course at all the 
concentrations to identify the right time. The hydrolysis reaction was stopped by adding 1N ace-
tic acid. After cooling down, 5x SSC was added to the RNA sample, applied on the chip and hy-
bridization done for 20 minutes. Thereafter, BA RNA was added and hybridization done for fur-
ther 15 minutes. The unbound RNAs were washed twice with pre-warmed PBS buffer (137 mM 
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, pH 7.4). The chips were then incubated with RNase H 
(0.5 µL, 5000 U mL/1) in RNase H buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, MA) at 
37 oC for 15 minutes. The digested RNAs were followed by incubation with Klenow large frag-
ment (0.5 µL, 5000 U mL/1) in Klenow buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, 
MA) and 1 µL of 0.4 mM; biotin labeled 14-dATP (Invitrogen, Carlsbad, CA) at 37 oC for 30 
minutes followed by washing three times with PBS buffer. This was followed by incubation with 
Poly-HRP streptavidin (Thermo Scientific, Rockford, IL) diluted 5000x in TBS buffer for 15 
minutes followed by washing (5x) with PBS to remove unbound enzymes. SuperSignal ELISA 
Femto Maximum sensitivity substrate (Invitrogen, Carlsbad, CA) was applied on the chips and 
the chemiluminescence signal captured immediately with a CCD camera. 
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Figure 5.2: Alkaline assisted fragmentation conditions optimization results. Similar 
amounts of total RNA (30 µg) were fragmented for 5 minutes and applied on each chip BA 
acted as positive control (25 fmol) and BF as a negative control. 
 
5.7  Metal assisted E. coli total RNA fragmentation 
Metal cations have been used as candidates to assist in degradation of nucleic acids to 
shorter fragments. Metal catalyzed fragmentation can generate fragment in the region of 50-100 
nucleotides.42 163 164 166 Research by Browns (2002) indicated Mg2+, Zn2+ and Ce3+ performance 
increased with decreased concentration of the three metals with the size of the RNA ranging 
between 50 – 100 nucleotides. Fragmentation was shown to substantially result in a significant 
enhancement of hybridization signal. Zn2+ and Mg2+ are also the main components of commer-
cially fragmentation buffers. 
Generally, lower temperatures and longer times are used for fragmentation methods but 
with an aim to develop rapid methods, higher temperatures and shorter times were investigated 
in our experimental set up with good results. Thermal and metal catalyzed, i.e. ZnCl2 and MgCl2 
fragmentation were investigated in this set-up. All fragmentation was done at ~92 oC and the 
metal ion concentration was 20 mM. Even though thermal denaturation has been shown to im-
prove signal, in our case, there was barely any signal observed as well as 20 mM MgCl2 (Figure 
5.3). As shown in figure 5.3, comparison with alkali catalyzed fragmentation indicates similar 
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results for 20 mM Zn2+ and 50 mM NaOH but Zn2+ catalyzed fragmentation was not consistent 
among batches which led to the use of 50 mM NaOH fragmentation as our method of choice. 
The positive control signal is very high even at lower femtomole. 
5.7.1 Experimental 
The chips were immobilized with three different probes; BF probe, lacZ probe and BA 
probe respectively. For metal ion-catalyzed fragmentations, the total RNA was incubated with 
20mM of MgCl2 and ZnCl2 in 25 mM of Tris-HCl (pH 7.4) at 92 
oC for 3 min each. Thermal frag-
mentation was done for 2 minutes while NaOH fragmentation was done for 5 minutes after 
which neutralization was necessary. After cooling down and centrifuging, 5x SSC was added to 
the fragmented total RNA and later applied to the chips. The chips were incubated at 37 oC for 
20 min after which 1 µL (10 nM) BA was added. This was further incubated for 15 minutes after 
which hybridization was stopped by washing the chips with mildly warm water. Further experi-
mental procedure on the chips was followed as outlined in alkali catalyzed fragmentation exper-
imental section (Section 5.6.1). 
 
Figure 5. 3: Metal assisted fragmentation. Similar amounts of total RNA (10 µg) was frag-
mented and applied on the chips. BF acted as a negative control. 
 
5.8. Specificity of detection 
Specificity was also illustrated using IPTG-induced E. coli and glucose-suppressed E. 
coli at 50 mM NaOH concentration. The two works in the opposite direction. IPTG is able to 
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mimic lactose as a carbon source which bind to the lac repressor which leads to transcription of 
the gene (Figure 5.4, chip A). The presence of E. coli can be detected by targeting lacZ gene. 
On the other hand, glucose indirectly inhibits the lac expression by reducing cAMP, therefore 
there is no cAMP-CAP complex that activates transcriptome by binding to promoter. In this 
case, the gene is not transcribed (Chip B). The RNA was fragmented at 92 oC in 50 mM NaOH 
for 5 minutes. 
 
Figure 5.4: Specificity of detection using E. coli total RNA. A; had IPTG-induced total 
RNA applied to it while B glucose-expressed total RNA. 
 
5.9 Direct detection of lacZ RNA from alkali lysed bacteria 
Direct lysis of cells with NaOH and sodium dodecyl sulphate (SDS) has been reported 
previously for the extraction of plasmid DNA from bacteria. Normally, SDS, an ionic detergent 
lyses the membrane by dissolving the phospholipids and protein components of the cellular 
membrane while NaOH loosens the cell walls and releases both the plasmid and chromosomal 
DNAs. NaOH also denatures the cells.167 168 169 The plasmid extraction protocol relies on potas-
sium acetate to precipitate the bacterial proteins, broken cell walls and nucleases. Upon centrif-
ugation, plasmid DNA and lower molecular weight RNA molecules remain in the supernatant. 
NaOH lysis of bacteria cells was envisioned as a simple alternative which may provide 
adequate RNA for the direct detection on the RNA microchip. This method will enable a simple, 
easy and rapid RNA extraction procedure devoid of enzymes, potentially hazardous organic 
solvents or commercial kits. After the simple workout, the supernatant should contain the nucle-
ic acids i.e. RNA and DNA for detection on the chip or other detection methods. RNA handling 
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time is reduced by several hours or days thus reducing degradation. The method is simple and 
cost-effective requiring only NaOH and acetic acid for neutralization purposes. The method is 
even easier than phenol/chloroform extraction that requires proteinase K for protein digestion 
before extraction among other reagents.161 
It can be observed that this simple NaOH treatment worked as shown on Figure 5.5. The 
E. coli cells were treated with 25 µL of 50 mM, 100 mM, 200 mM of NaOH for chips A, B, and C 
respectively. This was followed by neutralization after which the RNA was diluted in 5x SSC and 
applied to the chips. Chip B had the best signal followed by chip A. Precipitation on the surface 
was observed on chip C during hybridization step. Even washing with gently hot water could not 
help remove the white precipitate. This is an indication that the NaOH concentration was quite 
high to cause precipitation. Any kind of precipitation on a chip surface leads to a lot of back-
ground. Chip C indicates that BA which was added 20 minutes later can penetrate through the 
white precipitate. This can be attributed to the fact that BA synthetic RNA is short compared to 
the E. coli total RNA. 
Further conditions optimization was necessary to ensure no precipitation on the surface. 
Normally in all the other chips, 25 µL of NaOH was used for fragmentation but no more than 15 
µL was applied on the chip. Reduction of the NaOH volume and increase in concentration to 
give a final concentration of 200 mM was found to improve the results. 
5.9.1 NaOH treatment of E. coli cells and extraction of total RNA 
E. coli was generated as explained in the procedure above (section 5.3). For the optimi-
zation of NaOH fragmentation, the chips were spotted with three probes; a negative control 
(IL8), positive control (BA) and lacZ. Similar amount of pelleted E. coli (1 mL) was used in chips 
A, B and C. Three different NaOH concentrations were used; A; 50 mM; B; 100 mM and C; 200 
mM. The volume used on A, B, and C was 25 µL. The E. coli pellet was vortexed to mix and lat-
er heated at 92 oC for 5 minutes. The sample was cooled in ice, centrifuged and the precipitate 
was discarded. The supernatant was neutralized with 1N acetic acid and centrifuged briefly. 
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5.9.2   Detection on the microchip 
The NaOH extracted RNA (12.5 µL) was added to 5x SSC and applied on chips A, B 
and C respectively. The positive control was added 20 minutes afterward at 5 fmol. The other 
experimental procedure is as outlined in the alkali fragmentation section (Section 5.6.1). 
 
Figure 5. 5: Conditions optimization for NaOH E. coli total RNA extraction. Lysis and 
fragmentation accomplished at 92 oC for 5 minutes. 
 
5.10 Specificity of NaOH bacteria lysis and fragmentation on the microchip 
Specificity was tested using both IPTG-induced and glucose-suppressed NaOH extract-
ed total RNA. As explained above, glucose suppressed is a good negative control model which 
mimics the bacteria cell other than the synthetic RNA normally used. Figure 5.6 shows specifici-
ty results. Chip A had IPTG induced RNA while chip B had glucose suppressed RNA. Only a 
very small signal was observed on Chip B which means the extraction is quite specific. It is also 
good to note that the negative control did not show up in any of the chips. 
5.10.1 Experimental 
E. coli was generated as explained in the procedure above (Section 5.3). For the optimi-
zation of NaOH extraction, the chips were spotted with three probes; a negative control (IL8), 
positive control (BA) and lacZ. 25 µL of 100 mM NaOH was added to two tubes with 1 mL of 
harvested E coli pellet and vortexed to mix. Tube A contained IPTG-induced E. coli while tube B 
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contained glucose-suppressed E. coli. The tubes were incubated for 5 min at 92 °C. After cool-
ing, the tubes were centrifuged; the supernatant was removed and neutralized with 1N acetic 
acid. The supernatant (12.5 µL) was mixed with 5x SSC and applied on chip A and B respec-
tively. BA (5 fmol) was applied to the chips after 20 minutes. The rest of the procedure was fol-
lowed as indicated in alkali fragmentation section (Section 5.6.1). 
 
Figure 5.6: Specificity of NaOH lysis and E. coli fragmentation. 
 
5.11 Detection of lacZ mRNA on the microchip without neutralization 
Interestingly, it was observed that the NaOH extracted RNA could be directly detected 
on the chip without neutralization (Figure 5.7). These unexpected results could have been pos-
sible because the handling time is less therefore the RNA was not hydrolyzed to destruction as 
is normally believed. Even RNA as short as 40 nt (BA) could be detected by incubation at this 
harsh alkali conditions.  
As previously noted, fragmentation was done using 25 µL of NaOH but not more than 
12.5 µL of the supernatant was added on the chip. There was therefore more sample left over 
render direct measurement of the E. coli used void. Further fragmentation conditions were de-
signed to reduce the volume of NaOH used but at the same keep the amount of NaOH the 
same. Different concentrations were therefore tested with 400 mM (6.5 µL) giving the best sig-
nal. This amount gives the final NaOH concentration as 200 mM. More E. coli (1.5 mL) was also 
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used to avoid the uneven hybridization on the chip as represented by the black holes at the cen-
tre of the spot. With this condition, there was no precipitation and the signal is better and clean-
er as compared to the others. Further simplification involved elimination of neutralization step 
which also gave a positive signal (Figure 5.7). It can be concluded that NaOH not only improved 
extraction but also fragmentation as observed with the high hybridization signal. 
5.11.1 Experimental 
E. coli was generated as explained in the procedure above (Section 5.3). For the optimi-
zation of NaOH extraction, the chips were spotted with three probes; a negative control (IL8), 
positive control (BA) and lacZ. Total RNA from E. coli cells (harvested form 1.5 mL) were heated 
with 6.5 µL of 400 mM at ~92 oC for 5 minutes. This was followed by cooling down, centrifuging 
for a few minutes. The RNAs were mixed with 5x SSC and applied on each chip. The other pro-
cedure on the chip is as indicated in alkali fragmentation section (Section 5.6.1). 
 
 
Figure 5.7: Direct detection of NaOH lysed bacteria RNA without neutralization 
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5.12 Summary 
Direct and rapid detection of lacZ gene mRNA from E. coli total RNA was reported with 
high sensitivity. IPTG was used to induce the expression of lacZ mRNA while glucose repres-
sion afforded a negative control. The RNA microchip was specific for detection of lacZ from the 
bacteria total RNA. By using NaOH (50 mM), fragmentation of total RNA and detection thereaf-
ter gave the best results. Detection was accomplished to lower femtomole as indicated by the 
positive control signal. RNA probes with as low as 5 nt (5M) was also detected on the chip and 
discriminated from others. This is an indication that the RNA microchip can be used even with 
degraded RNAs; only 5 nt are required at the RNase H specific region. This is an important as-
pect since labeling of degraded probes with the current methods is not easy. 
A simple and rapid total RNA extraction protocol was also developed and validated. By 
treating bacteria cells directly with NaOH for 5 minutes, we are able to directly and specifically 
detect lacZ form IPTG induced bacteria cell lines only. The method is rapid with minimum RNA 
handling steps thus any person can be able to use it. Elimination of commercial RNA purification 
kits ensures cost effectiveness and results in a more rapid detection method. Detection was ac-
complished at 106 CFUs and even as low as 104 CFUs could be detected without amplification. 
NaOH lysis of bacteria is an easy and rapid method for extraction of total RNA and even gives 
better results. 
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6. DENGUE FEVER SEROTYPING ON THE RNA MICROCHIP 
6.1 Introduction 
Virus infections have been one of the most dangerous threats to human, animal and ag-
ricultural health. An example is the influenza pandemic, commonly referred to as Spanish flu of 
the early 20th century that caused more than 20 million deaths worldwide. Although the recent 
pandemic of the HIN1 influenza strain was far less dramatic, the current H7N9 is feared to be 
more deadly (WHO updates; 2013). Such infectious pathogens can cause much human suffer-
ing and widespread economic loss.170 171 The other most common pandemic viral infectious dis-
ease was HIV/AIDS which was clinically observed in 1981 in the US and by 2009, it had led to 
30 million deaths. Currently it is estimated there are ~30 million living with AIDs.172 Others in-
clude, West Nile virus, an arboviral infection prevalence in the US, the tropics and subtropics,173 
174 chikungunya virus, a positive RNA alpha virus175 and dengue virus, an arthropod-borne viral 
disease. The situation is complicated by re-emergence of the infectious diseases and a tenden-
cy to adapt to new environment.104 
Dengue is a viral disease transmitted by Aedes aegypti mosquito. It is estimated that 
greater than one-third of the world’s population lives in areas at risk for transmission.176 Dengue 
poses significant health risks for individuals living in the tropics and subtropics. As many as ~50 
million people are infected annually mainly in the Southeast Asia, the pacific and the Americas. 
Africa and Eastern Mediterranean are also having increased transmission.177 Sporadic cases of 
locally acquired disease have been reported in the US since 1980. Outbreaks have been re-
ported in Texas178 and most recently Florida.179 180 Dengue related infections are becoming the 
most common cause of fever among travelers in the United States. Dengue is therefore becom-
ing the most rapidly spreading vector-borne disease in the world. The world health organization 
(WHO) has been designated dengue as a major international public health problem. 
Dengue virus (DENV) belongs to the Flaviviridae family and consists of 4 related sero-
types, DENV 1-4. DENV is a spherical, positive single-strand RNA virus with a ~11 kb genome. 
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All DENV share around 65% of the genome. Despite this, the clinical manifestations range from 
asymptotic infections to a severe disease characterized by dengue hemorrhagic fever and/or 
dengue shock syndrome(DHF/DSS).181 182 Infection by one of the serotype provides a lifelong 
immunity against that particular strain but not the remaining three, with secondary infection lead-
ing to DHS/DSS. The asymptomatic nature of dengue makes it difficult to isolate the case in the 
early phase of infection. 
Dengue virus detection can be accomplished by testing either the viable virus, viral RNA, 
circulating viral antigens or host antibodies. Virus can be detected in the patient’s blood stream 
4-5 days after onset of illness. The early diagnosis methods include culture based method, anti-
gen detection and RT-PCR. After this incubation time, antibody detection offers the most sensi-
tive results.183 Antibody detection can be accomplished using five serological tests: 
hemagglutination inhibition (HI), complement fixation (CF), neutralization test (NT), immuno-
globulin M (IgM) and immunoglobulin IgG capture ELISA assays. While HI is the gold standard 
due to high sensitivity and reliability, the method lacks serotype specificity. ELISA antibody de-
tection kits are more developed with commercially available thus they are widely used. But de-
tection is complicated by a number of factors including the availability of a large pool of anti-
gens, acquired immune response to infection, specimen type, the virus serotypes, presence of 
cross-reacting co-circulating flavivirus antibodies as a result of prior infection or vaccination as 
well as antigens used in ELISA. Both the IgM and IgG test also responds to antibodies for other 
flavivirus including, yellow fever and West Nile virus thus resulting in cross contamination. 
Therefore a researcher should put all these entire factors into consideration to achieve a correct 
ELISA diagnosis. Furthermore, the antibodies are better detected around the fifth day of disease 
onset making this unfeasible for rapid detection.184 
Molecular based detection methods have an advantage of targeting the unique genome 
of the virus. Nucleic acid hybridization assays e.g. RT-PCR, real-time PCR and NASBA have 
also been developed for dengue diagnosis.176 185 These tests could offer early diagnosis there-
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fore lowering the risk of developing a severe disease. However, none of these tests have been 
approved by the Food and Drug Administration (FDA). WHO only considers PCR and RT-PCR 
as experimental methods for dengue detection. Besides, the two methods are limited in serotyp-
ing the four dengue viruses and often requiring extensive work to identify one or all of them. 
There is therefore a need for a rapid, low cost and reliable diagnosis method that can 
identify the serotypes in the early phase. The molecular based detection method can also identi-
fy biomarkers that can help understand and predict the progression from classic dengue fever to 
the severe forms of the disease and better understanding of the pathogenesis of the disease. In 
addition, dengue diagnosis will be of importance for research in host, virus and vector character-
istics, epidemiological conditions as well as antiviral drug and vaccine development. The RNA 
microchips are sensitive, rapid and have greater power in discrimination of SNPs which is an 
important aspect since the DENV viruses differ by single or a few mutations in their genome. 
Rapid and early detection will help in patient management which can lower the risk of develop-
ing severe disease. Development of a rapid, sensitive, accurate and cost-effective RNA micro-
chip for DENV viral serotyping is investigated. 
6.2. Results and discussion 
6.2.1 DENV probe design and immobilization on the microchip. 
The target RNAs and hybrid probes were designed from the DENV RNA genome for 
serotyping on the RNA chip. Four target RNAs were chosen from specific regions of the four 
DENV genomes to enable specific detection of each one of them. There was an inclusion of a 
general RNA that could target all four of them. The general RNA was same in all four serotypes. 
The hybrid probes are complimentary to the target RNAs.102 All the probes were modified with 
an amino group which affords immobilization on the chip surface. The probes have two regions; 
RNA region that is 2’-O-methylyted and the other portion is a DNA region which serves as a 
guiding template for polymerase extension. The 2’-O-Methylation stabilizes the RNA region and 
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protects it against RNases.109, 108, 141 Figure 6.1A is a general probe that can target all the sero-
types while Figure 6.1B is the four DENV serotype probes with SNPs highlighted against DENV-
1. All four serotypes maintain their names in this dissertation while the general probe is named 
DENV-5. 
A. DENV-1 RNA (Accession no.: U88536.1; 10627-10648 nt): 5’-AAACAGCAUAUUGA-CGCUGGGA-3’ 
DENV-2 RNA (Accession no.: U87411.1; 10617-10638 nt): 5’-AAACAGCAUAUUGA-CGCUGGGA-3’ 
DENV-3 RNA (Acc. no.: AY099336.1; 10599-10620 nt): 5’-AAACAGCAUAUUGA-CGCUGGGA-3’ 
DENV-4 RNA (Acc. no.: AF326825.1; 10541-10562 nt): 5’-AAACAGCAUAUUGA-CGCUGGGA-3’ 
DENV-5 (General probe) of all four dengue serotypes: 5’-TCCCAGCG-[2’-Me-r(UCAAUAUGCUGUUU)]-NH2-3’ 
 
B. DENV-1 RNA (Acc. no.: U88536.1; 10484-10504 nt): 5’-GGAAGCUGUACGC-AUGGGGUA-3’  
 DENV-2 RNA (Acc.: U87411.1; 10470-10490 nt): 5’-GGAAGCUGUACGC-AUGGCGUA-3’ 
 DENV-3 RNA (Acc. no.: AY099336.1; 10457-10477 nt): 5’-GGAAGCUGUACGC-ACGGUGUA-3’ 
 DENV-4 RNA (Acc. no.: AF326825.1; 10393-10413 nt): 5’-GGAAGCUGUACGC-GUGGCAUA-3’ 
 DENV-1 Probe 1: 5’-TACCCCAT-[2’-Me-r(GCGUACAGCUUCC)]-NH2-3’ 
 DENV-2 Probe-2: 5’-TACGCCAT-[2’-Me-r(GCGUACAGCUUCC)]-NH2-3’ 
 DENV-3 Probe-3: 5’-TACACCGT-[2’-Me-r(GCGUACAGCUUCC)]-NH2-3’ 
 DENV-4 Probe-4 5’-TATGCCAC-[2’-Me-r(GCGUACAGCUUCC)]-NH2-3’ 
Figure  6.1: The probes were designed using different regions of viral RNA genomes. (A) 
for dengue general probe detection using regions with identical RNA sequences across 
all serotypes; (B) for individual serotype detection. Underlined sequences are viral RNAs 
complementary to italicized 2’-O-Me-RNAs of RNA probes. 
 
6.2.2 Chemiluminescence detection of DENV serotypes using 3’-labeling technique 
Chemiluminescence detection on the RNA microchip can afford a fast, sensitive and di-
rect RNA detection. The specific probes are able to capture the target RNAs on the RNA micro-
chip. Internal RNase H digestion exposes the Klenow template which allows incorporation of 
biotin dNTPs. Use of streptavidin HRP followed by ELISA substrates generates the desired 
chemiluminescence signal (Figure 6.2). 
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First, all the probes were tested to ensure they worked on the chip. Figure 6.3 is an ex-
ample of DENV-3 probe concentration optimization results. DENV-3 probe was immobilized at 
four different concentrations i.e. 50-300 µM. 500 fmol RNA was applied on the chip with hybridi-
zation, RNase H digestion and Klenow polymerization performed at 37 °C. Results indicate an 
increasing level of signal with increase in the concentration of the probe. This phenomenon was 
observed across all DENV RNAs with the exception of DENV-4 which showed only slight differ-
ences. A choice was made to keep 100 µM as the working probe concentration which would 
ensure low level of cross contamination in the presence of other probes. Therefore, 100 µM 
probe concentration was used in all the experiments. It is important to note that 50 µM also 
works with a high signal but the hybridization competition in this case reduced the signal. 
 
 6.2: Flow chart for the direct DENV serotyping RNA microchip. DENV-3 probe was immo-
bilized on the chip. RNA (red) binds via complimentary base pairing to the probe. RNase 
H then digests the RNA portion of the RNA/DNA duplex. The resulting single stranded 
portion of the DNA acts as a guiding sequence for Klenow incorporation with biotin la-
beled dNTPs. Streptavidin HRP binds to biotin which produces chemiluminescence sig-
nal upon ELISA substrate addition. 
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Figure  6.3. DENV-3 probe condition optimization. Denv-3 Probe: 3’-NH2–2-O-Me-
(CCUUCGACAUGCG)TGCCACAT-5’. DENV-3 RNA; 5’-GGAAGCUGUACGC-ACGGUGUA-
3’. RNA hybridization, RNase H digestion and Klenow incorporation were done at 37 oC. 
 
6.2.3 RNA concentration optimization 
Further optimization of RNA was done by spotting all the probes as shown on Figure 6.4 
but only DENV-4 RNA was applied on both chips; 500 fmol on chip A and 100 fmol on chip B. 
RNA hybridization (15 min), RNase H digestion (15 min) and Klenow polymerization (30 min) 
were all performed at 55 oC. As shown on both chips, DENV-4 signal was comparable at both 
RNA concentrations but 100 fmol RNA had better specificity. Chip B had relatively low cross hy-
bridization as observed with DENV-1 and DENV-2 signal but this can be eliminated with further 
conditions optimization. This led to choice of 100 fmol RNA as the working concentration for all 
other experiments. The experiments were done at elevated temperatures to improve stringency 
which also improved the signal. 
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Figure  6.4. DENV-4 conditions optimization. Five DENV probes (100 µm) were spotted on 
the chip. Different DENV-4 RNA concentrations were applied on each chip; chip A had 
500 fmol while chip B had 100 fmol. RNA hybridization, RNase H digestion and Klenow 
were done at 55 °C 
 
6.2.4 DENV-2 detection on the RNA microchip 
As shown with the RNA genome, DENV serotypes only differs with a few mutations. It is 
important to note that while the symptoms are similar and asymptotic, secondary infection can 
be quite severe. This spurs the need for DENV serotyping on the RNA chip as a valuable indica-
tor for clinical diagnosis. This will help in infection management and disease therapy which 
could prevent occurrence of DHF/DSS thereby helping save lives. But there is lack of a simple, 
reliable and easy to use molecular detection method that can differentiate all the four serotypes. 
The RNA microchip could be a versatile tool for serotyping the virus. 
SNPs often introduce perturbations to the double helix which in turn reduces the binding 
interaction and stability of the duplex which is commonly characterized by lower Tm. By taking 
advantage of this unique duplex stability, one can be able to differentiate between closely relat-
ed species. Conditions optimization will eliminate detection resulting from cross hybridization 
which can result in false positives. False positives could be detrimental in life threatening situa-
tions especially when one gets a second infection with a different serotype.176 186 
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By taking advantage of the SNPS effect on hybrid stability on the RNA microchip, we 
can be able to detect all four serotypes specifically. These requires conditions optimization to 
ensure only the perfect match are able to form a hybrid duplex. As shown in Figure 6.1B above, 
all four DENV target RNA differ from DENV-1 by 1, 2, 3 respectively, but taken individually, each 
DENV differ from each other by different SNPs, therefore, it is important to be able to differenti-
ate each one of them from the others. As shown in Figure 6.4, DENV-4 was easily differentiated 
from each other but DENV-2 proved a formidable task with various different conditions tested. 
Below is the probe sequence with SNPs underlined in relation to DENV-2 while Figure 5 shows 
some of the conditions tested on the chip to ensure DENV-2 RNA specific detection. 
DENV-2 RNA:                 5’-GGAAGCUGUACGCAUGGCGUA-3’ 
DENV-2 Probe: 3’-NH2–2-O-Me-(CCUUCGACAUGCG)TACCGCAT-5’ 
DENV-1 Probe: 3-NH2–2-O-Me-(CCUUCGACAUGCG)TACCCCAT-5’ 
DENV-3 Probe: 3’-NH2–2-O-Me-(CCUUCGACAUGCG)TGCCACAT-5’ 
DENV-4 Probe: 3’-NH2–2-O-Me-(CCUUCGACAUGCG)CACCGTAT-5’ 
 
 
Figure  6.5: Optimization of conditions for DENV-2 target RNA. All the probes were printed 
on the chip at 100 µm. The conditions for RNA hybridization, RNase H digestion and 
Klenow incorporation are as shown below each chip. 
 
As shown in the Figure above, DENV-2 RNA detection had notable hybridization compe-
tition with DENV-1 and DENV-4. From the sequences, there is only one single nucleotide be-
tween DENV-2 RNA and DENV-1 RNA. It appears that a C:C is well tolerated during hybridiza-
tion and enzymatic incorporation. This could be explained by the fact that the C:C is small thus 
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don’t afford very high perturbation but with temperature control, specificity can be achieved. 
DENV-4 was consistently observed even though DENV-2 and DENV-4 differs by two SNPs and 
hybridization will afford A: C and G: T mispairing (chip B and D). It is amazing how this two are 
tolerated even by RNase H and Klenow. Specificity was only afforded at high temperatures and 
the reduction of time with RNA hybridization, RNase H digestion and Klenow incorporation done 
at 2 minutes (Chip E). While detection at two minutes indicates the possibility of development of 
a very rapid RNA chip, the signal was not consistent. Lower salt concentrations for hybridization 
step has been shown to increase stringency by forcing the partially complimentary sequences to 
remain apart, but in our case, 2x SSC and 1x SSC did not increase specificity, in fact only 
DENV-1 and DENV-4 had a higher and comparable signal than DENV-2 (data not shown). Even 
though the enzymes used are not thermostable, they seemed to work well up to 70 °C with very 
low signal above this temperature (Chip B). This can be attributed to the short reaction times for 
the enzymatic steps. It is also important to note that high degree of caution is required when do-
ing these experiments to avoid cross contamination attributable to human error. 
6.2.5 RNA microchip for DENV serotypes detection 
Conditions optimization was done for all DENV target RNAs to find a condition that could 
afford the highest specificity against other RNAs. Figure 6.6 shows the signal and the conditions 
for each probe which afforded the best specificity. Since DENV-5 is a general probe, optimiza-
tion was not necessary but the most common condition was used in this case. Except for 
DENV-2, all the others there serotypes (DENV-1, DENV-3, DENV-4) were well discriminated in 
the presence of other probes at a very high confidential level. DENV-3 was easily discriminated 
at mild conditions compared with the others but the high stringency conditions should be okay. 
As noted above, DENV-2 specificity was also achieved detected but it requires high stringency 
conditions for specific results. Even then, signal spreading was observed. Figure 6.6 shows the 
final DENV serotyping results on the RNA microchip. 
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Figure  6.6: Similar probes were printed on each chip but different serotype specific RNA 
was applied on each chip. T oC stands for temperature while t stands for time in minutes. 
 
By targeting the genome which is specific for each serotypes, we are able to avoid the 
limitations observed with the serological tests as mentioned in the introduction, i.e. HI, CF, NT, 
IGM –ELISA test.176 187 These limitations include cross-reactivity thus requiring a comprehensive 
pool of antigens, the four serotypes and other flaviviruses causing similar clinical manifestations. 
In addition, the test can only be done five days after infection. IgM levels have been shown to 
vary in patients, infection period and the serotypes as well a consequent secondary infection. 
This complicates results interpretation. The RNA microchip will therefore be a great tool since 
the genome can be detected as early as the symptoms are observed with specific results by use 
of target specific probes. Detection of two different DENV RNAs can also be an indication of 
secondary infection and proper measures can be taken to reduce severe form of dengue fever. 
Molecular methods such as nested PCR and RT-PCR have also been used for detection 
and serotyping studies.186 184 Generally, these methods report dengue infection without an indi-
cation of which serotypes further method modification can allow multiplex analysis that allow 
serotyping. The amplification methods can be time consuming because of the rigorous steps 
required from primer design and synthesis, RNA extraction, RT-PCR and fractionation. In addi-
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tion, nested PCR involves two PCR reactions and only one serotype can be identified.188 On the 
other hand, RT-PCR can be used for serotyping but this requires labeling each probe with a 
specific signal reporter and the subsequent signal analysis is time consuming.189 185 Besides, 
PCR amplifications are prone to errors even though the primers are designed from regions 
without mutations. But in our case, only four probes are required to serotype the viruses. The 
RNA microchip is more superior in single nucleotide polymorphism, sensitive, fast and offers a 
direct detection method without amplification. 
6.3. Experimental 
6.3.1. DENV RNA probe design and immobilization on the RNA microchip. 
The target RNAs and hybrid probes were designed from the RNA genome with inclusion 
of a general probe that was identical in all four serotypes. The probes were synthesized in our 
lab by using solid phase phosphoramidites chemistry and thereafter purified using Glen Pak 
column. The hybrid probes were diluted to 100 µM with sodium phosphate buffer (100 mM, pH 
8.5) followed by printing on the functionalized microchip using Omnigrid Micro (Cartesian Tech-
nologies Inc., Irvine, Ca, U.S.A). Immobilization was achieved by incubation at 37 oC for 30 min. 
6.3.2. DENV serotypes detection on the RNA microchip 
After immobilization, the chips were incubated with StartingBlock (TBS, Pierce, Rock-
ford, IL) blocking buffer for 20 min. The chips were then flooded with 100 fmol target RNA in 5 x 
SSC buffer (0.75 mM NaCl, 75 mM sodium citrate, pH 7.0) followed by incubation at elevated 
temperatures and time. The unbound RNAs were pipette off followed by incubation with RNase 
H (0.5 µL, 5000 U mL/1) in RNase H buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, MA) 
at elevated temperatures with different time courses. The digested RNAs were then pipette off 
followed by incubation with Klenow large fragment (0.5 µL, 5000 U mL/1) in Klenow buffer (20 
µL, 1x New England Biolabs® Inc, Ipswich, MA) and biotin labeled dNTPS (0.25 µL per chip, 0.4 
mM); biotin 14-dATP (Invitrogen, Carlsbad, CA), biotin 14-dCTP (Invitrogen, Carlsbad, CA), bio-
tin 11-dGTP (PerkinElmer, Waltham, MA) and biotin 11-dUTP (PerkinElmer, Waltham, MA) at 
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elevated temperatures followed by washing with PBS buffer. Thereafter, the chips were incu-
bated with Poly-HRP streptavidin (5000x) in TBS buffer for 15 minutes (Thermo Scientific, Rock-
ford, IL). The unbound enzyme conjugates were rinsed five times with PBS. SuperSignal ELISA 
Femto Maximum sensitivity substrate (Invitrogen, Carlsbad, CA) was then applied to the chip 
and the chemiluminescence signal captured using a CCD camera. 
6.4. Summary 
Our study describes rapid, specific and easy to use method for early detection of dengue 
viruses. Even the though the genome differs by only small regions, we are able to discriminate 
the serotypes. by designing DENV serotype specific probes. The probes target regions that are 
similar but differ with a few mutations. Specificity studies indicate each of the DENV serotypes 
can be detected individually in the presence of other DENV probes. This was made possible 
designing DENV serotype specific probes to target each probe. Further specificity is afforded by 
RNase H and Klenow incorporation to ensure only the present RNA was detected in the pres-
ence of the DENV probes. This method is highly specific both at the 2-O-Me region and the 
Klenow template.113  
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7. RNA MICROCHIP BASED ON GOLD NANOPARTICLES DETECTION 
7.1 Introduction 
Gold nanoparticles (AuNPs) based nucleic acid detection methods have become the ba-
sis of an increasing number of diagnostic applications. Methods utilizing oligonucleotide func-
tionalized gold nanoparticles takes advantage of the Au affinity for sulpur and their intense sur-
face plasmon resonance and the capabilities for controlling particle size and composition.88, 190 
191 192 193 Upon hybridization with the target, AuNPs afford various read out methods such as 
optical detection methods; light scattering, spectroscopy i.e. surface-enhanced Raman (SERS) 
as well as electrochemical methods.192b 194 86 195 
Another technique is the use of gold nanoparticles functionalized protein probes e.g. 
streptavidin. 88 196 The target is labeled with biotin which upon binding with streptavidin provides 
a reporter system for signal generation. Silver staining relies on the gold autocatalytic nature 
which reduces silver ions into metallic silver. The silver shell around AuNPs also autocatalyzes 
further depositions resulting in a signal enhancement with a growth of nanoparticles. The signal 
generated by this methods result from precipitation of silver on labeled AuNPs. Silver enhance-
ment is electron dense thus the images can be detected by naked eye or by use of a visible light 
scanner or an instrument that measures scattered light from the silver spots.87, 196-197 198,199 200 201 
Streptavidin labeled AuNPs offers an advantage over oligonucleotide labeled AuNPs 
since the latter involves preparation of specific probes for each application. The silver staining 
process is an autocatalytic process allowing signal amplification up to 100 times. The metallic 
deposition is not quenched and does not decompose thus can be stored for a long time where-
as fluorescence intensity is sensitive to a variety of quenchers including glass surfaces and the 
molecules tend to decompose. Also, the same visual detection chip can be used as a light re-
flection-based chip since silver strongly reflects/scatters light in a visible spectrum. A single na-
noparticle can scatter as much as 106 fluorescein molecules and are resistant to photo bleach-
ing.192b The method can be used for various support surfaces other than glass e.g. acrylic layer 
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in comparison with fluorescence detection for which plastic arrays cannot be used due to the 
strong auto fluorescence of polymers. Silver deposit is stable and can be stored for a long peri-
od of time. Use of AuNPs provides a rapid, specific and low cost detection of nucleic acids. The 
visual detection RNA chip will be a powerful tool in pathogen global gene expression profiling,38 
pathogen detection,202 drug development and cancer therapeutics.36a 
To take advantage of this technology and tackle RNA detection challenge, we have de-
veloped a rapid RNA detection on RNA microchip based on AuNPs and silver staining. The 
method takes advantage of nucleases and polymerase activities which allows direct detection of 
mRNA using biotin labeled dNTPs and streptavidin AuNPs. Silver staining leads to autocatalytic 
deposition of zinc metal on the AuNPs. The signal is captured using a CCD camera. The color-
imetric silver detection can be used as a rapid, easy and sensitive tool for pathogen detection. 
The method specificity will be investigated by use of DENV virus RNA and lacZ mRNA. Devel-
opment of a multi-marker detection sensor will be investigated using HNC RNAs and different 
pathogenic RNAs. Sensitivity and rapidity which are also desired properties for a biological sen-
sor will also be investigated using lacZ. Biological sample detection and application into patho-
gen detection will be evaluated using lacZ mRNA. 
7.2. Pathogen mRNA detection 
7.2.1  Introduction 
Bacterial and pathogens pose a significant threat to human, animal and agricultural 
health. B. anthracis has been posed as a biological weapon for a long time.203 204 More recently, 
the 2001 anthrax attacks lead to 22 infections, 5 deaths, and over $1 billion damages. More 
hoaxes were reported which cost the United States government millions of dollars. Predominant 
techniques for pathogen detection rely on conventional microbiology approaches which are la-
borious, time-consuming and require labile natural products. Detection of pathogens through 
nucleic acid based technologies is a promising approach especially with our multi-marker plat-
form. Development of rapid, sensitive and specific assays for these organisms is necessary in a 
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number of fields including food safety, animal health care, diagnostics, pathology and clinical 
research, bio-defense and forensics. 
7.2.2 Target selection 
Infectious disease has been a major challenge to human development and survival. Epi-
demics of old and emerging infectious diseases coupled with unpredictable outbreaks continue 
to be a global burden.104 Also rapid and direct detection of infectious agents feared as bioterror-
ism agents such as B. anthracis and H1N1 influenza is needed to reduce the effect of such out-
breaks. Morens et al., have outlined a wide range of infectious diseases occurring globally 
which include viral and bacterial infections.104 Once the target has been selected, the next step 
is selection of gene of interest from the targeted organism. The gene or protein chosen should 
be species specific e.g. the lethal factor (LF) gene for B. anthracis is not present in any other 
member of the Bacillus family.204 Table 6.1 shows the species and the gene targets selected for 
this study. The target mRNAs sequence were selected from a region that had several concur-
rent A`s. An alignment with BLAST ensures the sequences are targets specific. 
 
Table 7.1: Gene selection table. The gene is selected from a protein or gene which en-
codes for a particular toxin or virulence factor 
Target  Gene  
E. coli (Wild type)  LacZ  
Bacillus anthracis (BA)  Lethal factor (LF)  
Bird Flu (H5N1; BF)  Matrix protein (M1)  
Avian Flu (H5N1; AF)  Matrix protein (M2)  
Dengue fever Viral RNA 
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7.2.3 Probe design and oligonucleotide library 
Probes were thereby designed from the target mRNA. Hybrid probes were designed as 
outlined in chapter 3 with the last DNA portion consisting of multiple Ts to enable incorporation 
of biotin labeled dATPs only which is a departure from HNC and DENV probes. The versatility of 
probe design enables a wide application of this method. Four different pathogens; E. coli, bird 
flu, avian flu and bacillus anthracis were synthesized for the model visual detection RNA micro-
chip. Below is the oligonucleotide library for multi-pathogen with the RNA genomic region indi-
cated in brackets. 
 
lacZ mRNA (lacZ, E. coli lacZ mRNA, 724-748 nt): 5’-AUGUGGAUUGGCGAUAAAAAACAA-3’ 
lacZ probe: 5’-d(GTTGTTTTTT)-2’-O-Me-RNA(AUCGCCAAUCCACAU)-d(CTGTGAAAGA)-
NH2-3’ 
Bacillus anthracis RNA (BA, B. anthracis lethal factor mRNA, 855-892 nt): 5’-
AUCUUUAGAAGCAUUAUCUGAAGAUAAGAAAAAAA-3’ 
BA probe: 5’-d(GATTTTTTT)-2’-O-Me-RNA(CUUAUCUUCAGAUAA)-d(TGCTTCTAAAGAT)-
NH2-3’ 
Bird Flu RNA [BF, Avian Influenza (H5N1) matrix protein 1 (M1) mRNA, 692-729 nt]: 5’-
AAUCUUCUUGAAAAUUUGCAGACCUACCAAAAACGA-3’ 
BF probe 1: 5’-d(TCGTTTTT)-2’-O-Me-(GGUAGGUCUGCAAAAUUUU)-d(CAAGAAGATT)-NH2-
3’ 
Avian Flu RNA [AF; Avian Influenza (H5N1) matrix protein (M2) mRNA, 838-872 nt]: 5’-CAU 
UUAUCGUCGC CUUUAAAUACG GUUUG AAAAGAG-3’ 
Avian Flu Probe: 5’-d(CT CTTTT)-2’-O-Me-(CAAAC CGUAUUUAAG)-d(GCGACGATAA ATG)-
NH2-3’ 
Biotin labeled DNA for rapid detection (lacZ DNA): 3’-NH2-
AGAAAGTGTCTACACCTAACCGCTATTTTTTGTTG-biotin-Cy3-5’ 
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7.3  3’-labelling technique 
Our lab has developed a method that affords labeling and detection of mRNAs in an 
RNA mixture. Our system is based on RNA 3’-labeling approach where a DNA polymerase in-
corporates hapten labeled dNTPs directly on a DNA template immobilized on a microchip.112 113 
Before incorporation of the labels such as biotin labeled dNTPs (Figure 7.1) the 3’-region is re-
moved by RNase H in the presence of a guiding sequence. This is followed by antibody conju-
gate binding using streptavidin AuNPs. Upon addition of silver staining solution (silver ions in 
the presence of a reducing agent), gold nanoparticles autocatalyze precipitation of silver metal. 
The images of the dark spots can easily be detected with the naked eye. 
 
Figure 7.1: Flow chart for the direct and visual detection RNA microchip. RNA (red) binds 
via complimentary base pairing to the last section of the chimeric probe. RNase H then 
digests the RNA portion of the RNA/DNA duplex. The resulting single stranded portion of 
the DNA acts as a guiding sequence for Klenow incorporation with biotin labeled dNTPs. 
Streptavidin labeled gold nanoparticles (AuNPs) binds to biotin which produces a visual-
ly detectable signal upon silver staining. 
 
7.4. Control experiments to identify the source of the signal 
Control experiments were also done to identify the source of the signal as shown in Figure 
7.2. It can be observed that absence of target RNA (chip A) and biotin labeled dNTPs (chip B) in 
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different chips doesn’t yield any signal as well as use of dNTPs with Klenow extension (Chip C). 
This concludes the source of the signal observed on chip D was as a result of RNA hybridization 
followed by RNase H digestion, Klenow extension with biotin-labeled dNTPs which upon binding 
with gold labeled streptavidin and silver staining afforded the desire signal (black spot). Blocking 
using StartingBlock blocking buffer reduces the background which is one of the challenges with 
silver staining experiments. Visual monitoring of the silver shell deposition on the glass surface 
allows one to monitor this step and cut it off when appropriate signal has been achieved. The 
pictures were captured using a CCD camera. 
7.4.1 Experimental 
Different probes designed from bird flu (BF) Avian flu (AF) lacZ and B anthracis (BA) 
were immobilized on four different chips for control experiments. The four chips were then incu-
bated with StartingBlock blocking buffer for 20 min. On all the chips, similar RNAs were applied 
in 5x SSC buffer (20 µL, 0.75M NaCl, 75 mM sodium citrate, pH 7.0) and incubated at 37 oC for 
15 min except for chip A. The unbound RNAs were washed twice with PBS buffer (137 mM 
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, pH 7.4)). The chips were then incubated with RNase H 
(0.5 µL, 5000 U mL/1) in RNase H buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, MA) at 
37 oC for 15 minutes. The digested RNAs were then washed twice with PBS buffer followed by 
application of Klenow large fragment (0.5 µL, 5000 U mL/1) in Klenow buffer (20 µL, 1x New 
England Biolabs® Inc, Ipswich, MA) and biotin labeled dATP (1 µL, 0.4 mM, Invitrogen, Carls-
bad, CA) on chips A and D while chip C had dNTPs applied to it. The chips were then incubated 
at 37 oC for 30 minutes followed by washing with PBS buffer. The chips were incubated with 
gold labeled streptavidin (4 µL) in gold conjugate dilution buffer (100 µL, KPL, Inc, Gaithersburg, 
Maryland) for 1 hour followed by washing with PBS buffer. Subsequently, 100 µL silver enhanc-
ing solution was applied until dark spots were observed. The chips were washed with a lot of 
water to stop further silver deposition and air dried. The pictures were taken using CCD camera 
with exposure time of 0.6s. 
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Chip A B C D 
RNA - x x x 
RNase H x - x x 
Biotin labeled dNTPs x x - x 
Streptavidin AuNPs x x x x 
Silver Staining x x x x 
 
Figure 7.2: Control experiments using gold labeled streptavidin. Similar probes were 
printed on each chip as shown in the figure. On chip A, targets RNAs were not applied 
while on chip B, target RNAs were applied but biotin-labeled dNTPs were not added at 
Klenow step. Chip C had target RNAs applied but dNTPs were used at the Klenow step 
other than biotin-labeled dNTPS. Chip D had everything applied to it resulting in a posi-
tive signal. 
 
7.5 Selectivity and simultaneous detection on the RNA microchip 
One main desirable properties for the RNA microchip will be the ability to selectively and 
simultaneously detect multiple target mRNAs in a sample. This will not only save time but also 
enhance the quality of the experimental results. Selectivity is important to ensure false positives 
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resulting from cross hybridization from other mRNAs are avoided. With the emergence of sev-
eral infectious agents, the RNA microchip will be of great help to identify the infectious target or 
targets as well as elucidate the strain or serotype. 
7.5.1 Visual multi-pathogen detection RNA microchip 
A microchip that allows for simultaneous detection of multiple pathogens may present a 
promising approach in detection of infectious diseases as well as epidemics in the field. For ex-
ample influenza viruses, a negative stranded RNA viruses are notorious for recurrent epidemics 
in many species including humans. Bird flu and avian flu outbreaks have been in the news re-
cently with new infections emerging across the globe (H7N9, 2013).These outbreaks pose an 
important diagnostic problem. In case of an outbreak, the RNA microchip can simultaneously 
use different markers to identify the pathogenic microorganism as well as the strain. The viability 
of the RNA microchip was tested using four different infectious targets with clinical importance 
i.e. bird flu (BF), avian flu (AF), B. anthracis (BA) and E. coli. 
The chips were immobilized with four different probes, namely, BF, AF, lacZ and BA as 
shown on the left side (Figure 7.3). The RNAs applied on each chip as indicated at the table be-
low each chip. As seen on Figure 7.3, only BA had a positive signal when only BA RNA was ap-
plied on Chip A confirming the selectivity of the method. Other chips show selectivity and simul-
taneous results for the pathogenic detection microchip. These results are an indication of the 
viability of the RNA microchip. KPL buffer is recommended for washing unbound AuNPs after 
conjugation. But this did not improve the signal thus PBS was retained for all washes except the 
final wash after silver staining. Use of one buffer systems also simplifies the procedure. 
Rapid and direct detection visual RNA microchip could revolutionalize diagnostics of 
pathogens around the globe. By designing specific probes for each target, any target can be 
detected directly on the chip. In situations where different pathogens have asymptotic symp-
toms, specific probes targeting each strain can be designed and detected on the chip. The sig-
nal on the RNA microchip can be visualized with naked eyes thus it can be used even in areas 
99 
with limited resources or without electricity. The technology requires minimum equipments mak-
ing it a good candidate for a point of care (POC) device. 
7.5.2 Experimental 
Four different probes BF, AF, lacZ and BA were spotted and immobilized on the chip. 
The chips were then incubated with StartingBlock blocking buffer for 20 min. Subsequently, the 
chips were flooded with different RNAs in 5x SSC buffer and incubated at 37 oC for 15 min. The 
unbound RNAs were washed twice with PBS buffer. The chips were then incubated with RNase 
H (0.5 µL, 5000 U mL/1) in RNase H buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, MA) 
(20 µL, 1x New England Biolabs® Inc, Ipswich, MA) at 37 oC for 15 minutes. The digested 
RNAs were washed twice with PBS buffer followed by incubation with Klenow large fragment 
(0.5 µL, 5000 U mL/1) in Klenow buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, MA) and 
biotin labeled dATP (1 µL, 0.4 mM, Invitrogen, Carlsbad, CA) at 37 oC for 30 minutes followed 
by washing with PBS buffer. The chips were incubated with gold labeled streptavidin (4 µL) in 
gold conjugate dilution buffer (100 µL, KPL, Inc, Gaithersburg, Maryland) for 1 hour followed by 
washing with PBS buffer. Consequently, 100 µL silver enhancing solution was applied until dark 
spots were observed. The chips were washed with a lot of water to stop further silver deposition 
and air dried. The pictures were taken using a CCD camera. 
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Figure 7.3: Selective and simultaneous detection of multiple pathogenic mRNAs on the 
RNA microchip. The chips were immobilized with the corresponding detecting probes; 
bird flu RNA (BF), Avian flu RNA (AF), lacZ RNA (lacZ), Bacillus anthracis RNA (BA). BA 
RNA was selectively detected by incorporating biotin labeled dATP into the RNA. Selec-
tive detection of A) BA or Simultaneous and selective detection of B) lacZ and BA RNAs 
and C) BF, AF and lacZ RNAs when the three were present in the sample, while BA probe 
was a negative control. D) Simultaneous and selective detection of all four RNAs. 
 
7.6 HNC Biomarkers identification on the RNA microchip 
Cancer detection is the most important step in cancer management and treatment with 
early detection leading to better treatment options and cure. Early detection of HNC has been 
shown to boost survival rates by more than 70%.115 A microchip that allows for early detection of 
HNC biomarkers may present a promising approach for early detection of HNC. For this micro-
chip to be effective in identifying biomarkers, selectivity is important which ensures false nega-
tives are avoided. 
The chips were immobilized with four different probes, namely, IGFBP1, IL8, VCAM1 
and BA as negative control. As shown in Figure 7.4, selectivity was demonstrated on chip A by 
detection of IGFPB1 RNA when only its RNA was applied on the chip while VCAM1, IL8 and BA 
probes acted as negative controls. Visual observation of the silver shell deposition on the glass 
surface also allowed one to monitor this step and cut it off when appropriate signal was 
achieved. Similarly, IL8 was selectively detected on chip B while the other probes acted as neg-
ative control. As observed, there was no interference or cross hybridization from other mRNAs. 
101 
Selectivity and simultaneous detection is demonstrated in other chips. In this case, different 
RNAs were applied onto chip C and D as indicated at the bottom of the chip. The main ad-
vantage was that the probes and RNAs could be used for both chemiluminescence detection 
and AuNPs silver staining method. This is not the case with methods that require labeling of tar-
gets during RT-PCR or use of thiol modified probes. Each detection method would require 
preparation of method specific probes. 
7.6.1 Experimental 
Different HNC probes; IGFBP1, IL8, VCAM1 and BA were immobilized on the chip for selec-
tivity and simultaneous detection studies. The chips were then incubated with StartingBlock 
blocking buffer for 20 min. Subsequently, the chips were flooded with different RNAs in 5x SSC 
buffer and incubated at 37 oC for 15 min. The unbound RNAs were washed twice with PBS 
buffer. The chips were then incubated with RNase H (0.5 µL, 5000 U mL/1) in RNase H buffer 
(20 µL, 1x New England Biolabs® Inc, Ipswich, MA) at 37 oC for 15 minutes. The digested 
RNAs were then washed twice with PBS buffer followed by Klenow incorporation step. Klenow 
large fragment (0.5 µL, 5000 U mL/1) in Klenow buffer (20 µL, 1 x New England Biolabs, Ips-
wich, MA) and 1 µL of 0.4 mM; biotin labeled dNTPs; biotin 14-dATP (Invitrogen, Carlsbad, CA), 
biotin 14-dCTP (Invitrogen, Carlsbad, CA), biotin 11-dGTP (PerkinElmer, Waltham, MA) and 
biotin 11-dUPT (PerkinElmer, Waltham, MA). (1 µL, 0.4 mM, Invitrogen, Carlsbad, CA) was ap-
plied on the chips and incubated at 37 oC for 30 minutes followed by washing with PBS buffer (3 
x). The chips were then flooded with streptavidin labeled AuNPs (4 µL) in gold conjugate dilution 
buffer (100 µL, KPL, Inc, Gaithersburg, Maryland) for 1 hour followed by washing with PBS buff-
er). Subsequently, 100 µL silver enhancing solution was applied until dark spots were observed. 
The chips were then washed with a lot of water to stop further silver deposition and air dried. 
The pictures were taken using CCD camera. 
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Chip A B C D 
IGFBP1 + + + + 
IL8 - + + + 
VCAM1 - - + + 
BA - - 
 
+ 
Figure 7.4: Selective and simultaneous detection of HNC biomarkers using streptavidin 
labeled AuNPs on the RNA microchip. The chips were immobilized with similar probes, 
three HNC probes i.e. insulin-like growth factor binding protein 1(IGFBP1), interleukin 8 
(IL8), vascular cell adhesion molecule 1 (VCAM1) and bacillus anthracis (BA) as control. 
IGFBP1 RNA was selectively detected by applying it on the chip A. The RNAs applied on 
the other chips are as indicated in the table below the chips. 
 
7.7 Specificity of detection on the RNA microchip 
7.7.1 Introduction 
Variation in the mRNA sequence can affect gene expressions as well as how humans 
responds to pathogens, chemicals, drugs, vaccines and other agents. SNPs which represents 
the most abundant form of genomic variation occurs at about one out of a thousand nucleotides 
in human genome.205 206 Some pathogenic bacteria strains and virus serotypes i.e. DENV only 
differs by SNPs which causes the virus to elicit different symptoms upon infection. SNPs are 
therefore regarded as potent genetic markers and valuable indicators for clinical diagnosis. 
Thus discrimination of SNPs for such species is important to ensure proper pathogen detection, 
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disease diagnosis and management. SNPs also present a variable molecular marker for drug 
development, disease therapy and biomedical research. Study of SNPs is therefore thought to 
be a key tool in genotyping and personalized medicine. The miniaturization, high probe density, 
selectivity and sensitivity of the RNA microchip technology offers the potential for simultaneous 
genotyping of SNPs. 
SNPs often introduce perturbations to oligonucleotides which in turn reduces the binding 
interaction and stability in duplex formation. Binding is possible but the interaction is less stable 
than that of a perfect match. As a consequence, perfectly matching strands usually generate a 
high signal than strands having a mutation.200 207 86 The application of the RNA microchip for di-
rect detection of SNPs requires demonstration and validation of the ability of the RNA chip to 
discriminate single base pair mismatches or related species. This will avoid false positives 
which could be detrimental in life threatening cases.205 
7.7.2 Bacillus anthracis detection on the RNA microchip 
To test the destabilizing effect of mismatches on our RNA microchip and the ability to 
discriminate SNPs, different probes were designed from Bacillus Anthracis. There are two main 
regions where mismatches can be introduced in our chimera probes, either the methylated re-
gion which stabilizes both the probe and target RNA or the Klenow template region. Introduction 
of mismatches in these regions will help us better understand the behavior of our probes. The 
mismatches are as underlined in the probe sequences (Figure 7.5). 
Specificity results indicate it is possible to distinguish between perfect and mismatches 
duplexes on the chip even at 37 oC and 500 fmol target RNA. Probe BA-1 had two mismatches 
in the 2`-O-Me RNA region while probe BA-3 had a mismatch in the Klenow template region. 
Probe BA-2, the perfect match had the highest signal compared with BA-3 although the differ-
ence between the two was only one mismatch in the Klenow guiding sequence. BA-1 with two 
mismatches in the 2’-O-Me RNA region had no detectable signal at these conditions indicating 
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the stability at this region is quite important especially because the region plays an important 
role in stabilizing the primer mRNA during RNase H digestion and polymerization. 
7.7.3 Experimental 
Different probes were designed from B. anthracis for specificity studies; BA-1, BA-2 and 
BA-3. After immobilization, the chip was incubated with StartingBlock (TBS, Pierce, Rockford, 
IL) blocking buffer for 20 min. The chip was then flooded with BA target RNA in 5x SSC buffer 
(20 µL, 0.75M NaCl, 75 mM sodium citrate, pH 7.0) followed by incubation at 37 oC for 15 min. 
The unbound RNAs were washed twice with PBS buffer (137 mM NaCl, 2.7 mM KCl, 4.3 mM 
Na2HPO4, pH 7.4). The chip was then incubated with RNase H (0.5 µL, 5000 U mL/1) in RNase 
H buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, MA) followed by incubation at 37 oC for 
15 minutes. The digested RNAs were then washed twice with PBS buffer followed by incubation 
with Klenow large fragment (0.5 µL, 5000 U mL/1) in Klenow buffer (20 µL, 1x New England 
Biolabs, MA) and biotin labeled dATP (1 µL, 0.4 mM, Invitrogen, Carlsbad, CA) at 37 oC for 30 
minutes followed by washing with PBS buffer. Subsequently, the chip was incubated with gold 
labeled streptavidin (4 µL) in gold conjugate dilution buffer (100 µL, KPL, Inc, Gaithersburg, 
Maryland) followed by washing with PBS wash. Consequently, 100 µL silver enhancing solution 
(1:1, BB International, Cardiff, CF14 5DX, UK) was applied until dark spots were observed. The 
chip was washed with water to stop further silver deposition on the AuNPs. Upon drying the pic-
tures were taken using CCD camera. 
105 
 
Figure 7.5: Schematic of the RNA microchip for the for the single nucleotide polymor-
phism (SNPs) studies. Different probes were immobilized on the chip. Mismatches were 
introduced at different sections of the probes as shown in probe A and C. 
 
 
Figure 7.6: RNA detection with single nucleotide polymorphism (SNPs). The probe could 
be discriminated by performing hybridization, RNase H and Klenow step at 37 oC. 
 
7.7.4 Dengue serotyping on the RNA microchip assisted by silver staining 
Virus infections pose a significant threat to human, animal and agricultural health. Den-
gue fever, also known as breakbone fever, is an infectious tropical disease caused by the den-
gue virus (DENV). The fever is caused by any of the four related viruses transmitted by mosqui-
toes, (DENV-1, DENV-2, DENV-3 and DENV-4). The four serotypes are mildly asymptomatic 
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and often difficult to recognize in the early phase of infection.182 But secondary infections with a 
different serotypes is characterized by severe forms of DSS/DHS. Besides, the genomes of the 
four serotypes differ with a few nucleotides. The SNPs can therefore be a valuable indicator for 
clinical diagnosis of DENV which will aid in disease therapy. Currently, there is a lack of a mo-
lecular method that can differentiate all the four serotypes. The application of the easy to use 
and cost effective RNA microchip for DENV serotyping was therefore demonstrated on the RNA 
microchip. 
Hybrid probes were designed from the naturally occurring DENV serotypes. The probes 
have two regions, 3’-NH2-2’-O-Me-RNA-DNA-5’. The probes were modified with an amino group 
at the 3’-end which affords immobilization on the chip surface. The RNA portion is 2’-O-
methylyted and the DNA region serves as a guiding template for polymerase extension. 
The four chips were immobilized with all four DENV probes and subjected to different 
conditions for optimization of DENV-1 RNA serotyping (Figure 7.7). As shown in the figure, chip 
A (5 pmol RNA) had a strong signal. Also, DENV-2 had a signal resulting from cross-
hybridization. This required more stringent conditions to eliminate DENV-2 signal, thus chip B 
RNA was reduced to 500 fmol but DENV-2 was still visible. But an increase in temperature to 65 
oC for the hybridization, RNase H and Klenow step led to increased specificity and chip C is a 
clear demonstration of the high specificity afforded on the RNA chip. The DENV-1 (300 fmol) 
virus was clearly discriminated at 65 oC for hybridization, RNase H and Klenow polymerization. 
As shown on the chip, increase in temperature increased stringency on the RNA microchip. This 
has a tendency of forcing weaker duplexes into single strands. DENV-1 can be detected even at 
lower fmol level but the signal is weaker (chip D). 
DENV-4 serotyping was easily achieved at elevated temperatures (55 oC) for RNA hy-
bridization (5 pmol), RNase H and Klenow incorporation. The high concentration required is an 
indication the duplex formation was very strong compared to the other mutated probes thus the 
specificity of the RNA microchip is very high. While this concentration is high, it is important to 
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note that lower fmol sensitivity can be achieved as will be discussed in the sensitivity experi-
ments. 
7.7.5 Experimental 
Different probes were designed from different section of DENV viral genomic RNA. The 
four DENV serotypes probes were spotted at 100 µM and incubated at 37 oC for 30 minutes. 
Afterward, the chips were incubated with StartingBlock (TBS, Pierce, Rockford, IL) blocking 
buffer for 20 min. The chip was then flooded with DENV-1 RNA in 5x SSC buffer and incubated 
at 65 oC for 15 min. The unbound RNA was washed twice with PBS. This was followed by incu-
bation with RNase H (0.5 µL, 5000 U mL/1) in RNase H buffer (20 µL, 1x New England 
Biolabs® Inc, Ipswich, MA) at 65 oC for 15 minutes. The digested RNAs were then washed 
thrice with PBS buffer followed by incubation with Klenow large fragment (0.5 µL, 5000 U mL/1) 
in Klenow buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, MA) and biotin labeled dNTPs 
(1 µL, 0.4 mM, Invitrogen, Carlsbad, CA) at 65 oC for 30 minutes followed by washing three 
times with PBS buffer. This was followed by incubation with gold labeled streptavidin (4 µL) in 
gold conjugate dilution buffer (100 µL, KPL, Inc, Gaithersburg, Maryland) followed by washing 
three times with PBS. Consequently, 100 µL silver enhancing solution (1:1, BB International, 
Cardiff, CF14 5DX, UK) was applied until dark spots were observed. The chip was washed with 
water to stop further silver deposition. Upon drying the pictures were taken using CCD camera. 
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Figure 7.7: DENV-1 SNPs discrimination using AuNPs. The probes were designed using 
different regions of viral RNA genomes. Underlined are SNPs which differ from DENV-1. 
 
 
Figure 7.8: DENV-1 serotyping on the RNA microchip. Discrimination was achieved at 65 
oC for RNA hybridization (300 fmol), RNase H and Klenow step. 
 
 
Figure 7.9: DENV-4 serotyping on the RNA microchip using AuNPs. Discrimination was 
achieved at 55 oC for RNA hybridization (5 pmol), RNase H and Klenow step. 
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7.8 Sensitivity of detection on the RNA microchip 
7.8.1 Introduction 
Sensitivity is one of the most important parameter for a biological sensor. This is be-
cause only a small amount of the biological material can cause contamination especially for the 
pathogenic probes. Other times it is not easy to get the labile materials and therefore one 
should be able to work with the lowest available material to achieve reliable and conclusive re-
sult. Detection on the RNA microchip can be done using biotin labeled probes or through our 
specific hybrid probes which allows for the incorporation of biotin dNTPs. Generally, most of the 
reported methods uses biotin labeled targets for AuNPS silver staining detection method.207 Our 
3’-labeling approach is a departure from this and allows direct detection of RNAs. 
7.8.2 Detection on the microchip using 3’-labeling technique 
Development of a microchip for pathogenic identification and detection requires a high 
level of sensitivity since sometimes there is not enough starting material. Generally many nucle-
ic acids techniques especially RNA detection methods require reverse transcription and PCR 
amplification. This not only requires additional time but also increases errors and artifacts. The 
3’-labelling technique enables direct detection of RNAs without polymerase amplification.102-103 
Development of a direct and sensitive RNA microchip that doesn’t require RNA enrichment or 
amplification and other processes thereof will only save time with improved results. Sensitivity 
was demonstrated by using of lacZ probes at different RNA concentrations on the chip with 0 
fmol lacZ applied on chip A), 5 fmol on chip B), 15 fmol on chip C) and 50 fmol on chip D. The 
method is sensitive for detection even to the lower fmol (Figure 7.10). 
7.8.3 Experimental 
The chips were immobilized with lacZ probe for 30 minutes after which they were incu-
bated with TBS blocking buffer for 20 min. The chips were then flooded with lacZ RNA at differ-
ent concentrations in 5x SSC buffer and incubated at 37 oC for 15 min. The unbound RNA was 
washed twice with PBS buffer. The chips were then incubated with RNase H (0.5 µL, 5000 U 
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mL/1) in RNase H buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, MA) followed by incu-
bation at 37 oC for 15 minutes. The digested RNAs were then washed twice with PBS buffer fol-
lowed by incubation with Klenow large fragment (0.5 µL, 5000 U mL/1) in Klenow buffer (20 µL, 
1x New England Biolabs® Inc, Ipswich, MA) and biotin labeled dATP (1 µL, 0.4 mM, Invitrogen, 
Carlsbad, CA) at 37 oC for 30 minutes followed by washing with PBS buffer. The chips were 
then incubated with streptavidin labeled AuNPs (4 µL) in gold conjugate dilution buffer (100 µL, 
KPL, Inc, Gaithersburg, Maryland) followed by washing with PBS wash buffer. Finally, 100 µL 
silver enhancing solution was applied until dark spots were observed. The chips were washed 
with a lot of water to stop further silver deposition. Upon air drying the pictures were taken using 
a CCD camera. 
 
Figure 7.10: RNA microchip detection sensitivity using lacZ RNA; images A–D; 0, 5, 15, 
and 50 fmol respectively. 
 
7.8.4 Detection on the microchip using biotin labeled RNA 
It was also necessary to demonstrate the sensitivity of the assay using biotin labeled 
RNA which is commonly used method for RNA detection. Normally, the probes are usually la-
beled during RT-PCR or chemical synthesis. In our set-up lacZ RNA was chemically labeled 
with biotin (24.2). E. coli lacZ probe was immobilized on the chip surface and later hybridized 
with different concentrations of biotinylated 24.2 RNA (Figure 7.11). Detection sensitivity was 
achieved at the lower fmol level without amplification. This labeling generally compares well with 
our methodology but prior labeling of the target RNA is required before detection on the chip. 
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7.8.5 Experimental 
The chips were immobilized with lacZ probe for 30 minutes after which they were incu-
bated with TBS blocking buffer for 20 min. The chips were then flooded with biotin labeled lacZ 
RNA at different concentrations in 5x SSC buffer and incubated at 37 oC for 15 min. The un-
bound RNA was washed twice with PBS buffer. The chips were then incubated with gold la-
beled streptavidin (4 µL) in gold conjugate dilution buffer (100 µL, KPL, Inc, Gaithersburg, Mary-
land) followed by washing with PBS buffer. Subsequently, 100 µL silver enhancing solution was 
applied until dark spots were observed. The chips were washed with a lot of water to stop fur-
ther silver deposition. Upon air drying the pictures were taken using CCD camera. 
 
Figure 7.10: Detection sensitivity with biotin labeled dNTPs. A) RNA detection sensitivity; 
images 1–4: 50, 5, 1 and 0 fmol of biotin labeled RNA, respectively. 
 
7.9 lacZ mRNA detection from E. coli total RNA 
7.9.1 Introduction 
For this method to be applicable for pathogen identification and cancer detection, it was 
important to demonstrate sensitivity using biological samples. Detection of specific mRNAs from 
total RNA presents a number of challenges. For one, it is not easy to label specific RNAs in an 
RNA mixture. Also, presence of other RNAs could also hinder the sensitivity of the method. 
Generally, the desired mRNA region is fished out of the total RNA mixture by PCR primers dur-
ing reverse transcription followed by polymerization, isolation and purification of the amplified 
DNA. DNA microarrays are afterward used to confirm PCR products. There is therefore a 
search for direct RNA detection method. The RNA microchip is devoid of pre-processing of 
RNAs and thus is rapid and can be used for direct measurement of transcription levels. 
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The wild type E. coli bacteria strain; K-12 MG1655 was selected as the target pathogen 
in evaluation of the RNA microchip for biological application. lacZ gene was induced in the wild 
type E. coli in the presence of IPTG. A negative control was achieved by using glucose to sup-
press lacZ gene expression. The E. coli total RNA was extracted using MasterPure RNA purifi-
cation kit followed by direct detection on the RNA microchip. 
The total RNA was directly detected on the chip as shown on Figure 7.12 (chip B). Also, 
specificity on the chip was confirmed by the lack of signal with glucose-suppressed total RNA 
(chip C). Chip A acted as negative control. The total RNA was treated with 100 mM NaOH with 
heating for 5 minutes at 92 oC before application on the chip for fragmentation purposes. As dis-
cussed earlier, the secondary structures and lengths of nucleic acids affect the rates of nucleic 
acids, leading to reduced hybridization efficiencies and false negatives, thus fragmentation of 
the total RNA before detection on the chip has been adapted for this research.163 208 
7.9.2 Experimental; preparation of E. coli total RNA 
The wild type E. coli bacteria strain, K-12 MG1655 was donated by Scarab Genomics 
(Madison WI). E. coli cells (5 µL) were grown in duplicate overnight in 6 mL Luria Broth (LB, 
Sigma Aldrich, St. Louis, MO) buffer at 37 oC with shaking at 220 RPM. The bacterium was then 
added to a 1L capacity Erlenmeyer flask containing 300 mL of sterilized LB buffer and cultured 
for 2 hours at 37 oC. Isopropyl β-D-1-thiogalactopyranoside (IPTG, Sigma Aldrich, St. Louis, 
MO) was then added to one flask and to the other D-(+) glucose (Sigma, St Louis, MO) was 
added to make a final concentration of 1 mM. The bacteria were cultured for 6 hours at 37 oC. 
The cells were harvested and the pellets stored at -80 oC for nucleic acid extraction. Total RNA 
of E. coli cells was extracted and purified according to MasterPure Complete RNA Purification 
Kit with some modifications (Epicenter Biotechnologies Madison, WI) and the RNA was dis-
solved in TE buffer [10mM Tris-HCl (pH 7.5), 1mM EDTA]. After purification, the purity and con-
centration of the total RNA were determined by measuring absorbance using UV-Visible spec-
trophotometer (Varian Inc., Sana Clara, CA). 
113 
7.9.3 Detection of lacZ mRNA from total RNA on the RNA microchip 
The chips were spotted and immobilized with lacZ probe. RNA fragmentation was car-
ried out by heating the total RNA (30 µg) in 100 mM NaOH for 5 minutes. The hydrolysis reac-
tion was stopped by adding 1N acetic acid. The RNAs were then added to 5x SSC and hybridi-
zation was done for 30 minutes. The unbound RNAs were washed with PBS buffer followed by 
RNase H digestion. The other procedures were followed as indicated in Section 7.8. 
 
Figure 7.12: Detection of lacZ mRNA from E. coli total RNA. Figure A) had no RNA ap-
plied, B) had IPTG-induced total RNA and C) had glucose-suppressed total RNA. 
 
7.10   Rapid and direct lacZ RNA detection from NaOH treated E. coli. 
7.10.1 Introduction 
The method developed for direct detection of E. coli in chapter 5 was applied in AuNPs de-
tection. As indicated earlier, RNA extraction from E. coli cells require a simple treatment with 
alkaline solution. NaOH treatment not only lyses the cells but also fragments the RNAs to ena-
ble faster hybridization. This quick RNA extraction step is simple and cost effective. The method 
reduces RNA handling time by several hours or days thus the RNA degradation process by 
RNases is reduced. The method is specific as shown (Figure 7.13; chip B) with absence of a 
signal in glucose suppressed total RNA. This simple method opens the application of the RNA 
microchip to regions where RNA purification kits are not available due to funding problems. The 
rapid and direct RNA detection shortens the RNA microchip detection method; culture growth 
and harvesting, extraction and detection on the chip can be accomplished within 24 hrs. This is 
a great improvement from the RNA purification procedures and cDNA microarray which require 
RT-PCR, labeling, purification and long hybridization times (16 hrs for hybridization only). 
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7.10.2 Experimental; E. coli growth, hydrolysis and detection on the microchip 
E. coli was prepared as previously described in 7.9 but was harvested in small portions 
for the lysis and hydrolysis purposes. Other than using commercial purification kit, total RNA 
was directly extracted and fragmented using NaOH. The chip was spotted and immobilized with 
lacZ probe for 30 minutes. RNA fragmentation was carried out by heating the bacteria (1.5 mL) 
with 400 mM (6.5 µL) NaOH for 5 minutes at 92 oC. The samples were cooled down, centrifuged 
and the supernatant aliquoted. This was followed by addition of 1N acetic acid for neutralization. 
The RNA samples were added to 5x SSC and applied on the chip. Hybridization was done at 37 
oC for 35 minutes followed by washing with PBS buffer (3 x). The other procedures are as out-
lined in Section 7.8. 
 
 
Figure 7.13: Rapid detection of NaOH treated E. coli bacteria; A) RNA extracted from 
IPTG-induced E. coli while B) is RNA extracted from glucose-suppressed E. coli. 
 
7.11 Rapid detection on the RNA microchip 
7.11.1 Introduction 
Rapid detection of pathogens using the RNA microchip would greatly benefit many fields 
especially in the outbreak of food borne diseases. Infections are generally caused by consump-
tion of contaminated subjects and are accelerated by person to person contamination. Rapid 
detection will come in handy in identification of the source of contamination to prevent further 
damage. The device can as well be applied as a routine check in organic farms, meat and food 
processing industries as a preventive method to curb the potentially harmful E. coli among other 
food related pathogens. A rapid RNA detection microchip will therefore be a versatile tool in 
monitoring communicable diseases e.g. the recent flu outbreaks. 
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Here we present a simple and rapid detection of mRNA using RNA microchip. Since we 
use short oligonucleotides, hybridization rates are faster which have enabled us to develop a 
rapid method where detection can be accomplished in one hour.208-209 There are several steps 
that can be optimized sequentially to ensure rapid detection (Figure 7.14, Figure 7.15 and Table 
7.3). As shown, the reaction can be performed in one hour to afford a strong signal for the rapid 
detection. Three different probes were immobilized on the surface, lacZ labeled DNA as a posi-
tive probe, lacZ probe which was our testing probe and BA acted as a negative control probe. 
Rapid detection could also be possible by combining the RNA hybridization, RNase H 
digestion and Klenow incorporation steps. This way, one is able to save time and reagents. Fig-
ure 7.16b is a chip showing the results for the three combined steps for 15 minutes. This was 
accomplished by combining all the components with RNase H and Klenow buffer system (2:8). 
There was no need for 5x SSC in this set-up. This result is an indication of the ruggedness of 
the RNA microchip. 
7.11.2 Experimental 
Several conditions were tested on the chips (Table 3) the best conditions for chip 13 re-
ported here (Figure 7.16). The chip was immobilized with three different probes; biotin labeled 
lacZ probe, lacZ probe and BA probe. After immobilization, the chip was flooded with lacZ RNA 
sample at different concentrations in 5x SSC buffer and incubated at 37 oC for 5 min. The un-
bound RNAs were washed twice with PBS buffer. Consequently, The chip was incubated with 
RNase H (0.5 µL, 5000 U mL/1) in RNase H buffer (20 µL, 1x New England Biolabs® Inc, Ips-
wich, MA) followed by incubation at 37 oC for 5 minutes. The digested RNAs were then washed 
twice with PBS buffer followed by incubation with Klenow large fragment (0.5 µL, 5000 U mL/1) 
in Klenow buffer (20 µL, 1x New England Biolabs® Inc, Ipswich, MA) and biotin labeled dATP (1 
µL, 0.4 mM, Invitrogen, Carlsbad, CA) at 37 oC for 5 minutes followed by washing with PBS 
buffer. The chip was incubated with gold labeled streptavidin (4 µL) in gold conjugate dilution 
buffer (100 µL, KPL, Inc, Gaithersburg, Maryland) at 37 oC for 10 minutes followed by washing 
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with PBS buffer. Subsequently, 100 µL silver enhancing solution was applied and incubated at 
37 oC for 15 min upon which the dark spots were observed. The chip was washed with water to 
stop further silver deposition and air dried. The pictures were taken using CCD camera. Detec-
tion was achieved in less than 1 hour. 
 
Figure 7.14: Flowchart for the rapid detection microchip . There are several reactions that 
can be optimized, namely; hybridization, RNase H digestion, Klenow extension with bio-
tin dATPs, AuNPs binding and thereafter silver staining. 
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Table.7.2: Rapid detection optimization summary. There are several steps that were op-
timized in a stepwise manner to develop a rapid RNA microchip. Silver staining was ac-
complished in 5-20 minutes and picture was taken in 0.6 s using CCD camera. 
 
 
 
Figure 7.15: Rapid detection condition optimization. A few chips showing the results ob-
tained with different conditions for optimization. From chips 11, hybridization, RNase H 
digestion, Klenow extension with biotin dNTPs, AuNPs binding and silver staining were 
done at 37 oC with timings as shown in the table above. 
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Figure 7.16: Rapid detection of lacZ RNA on the RNA microchip. A) with biotin labeled 
lacZ probe (35.2) acting as a positive control while BA acted as negative control. The de-
tection was achieved in less than one hour. All steps were done at 37 oC. B) rapid detec-
tion on the microchip by combining the first three steps; RNA hybridization, RNase H di-
gestion and Klenow incorporation (15 minutes). 
 
7.13 Summary 
A versatile visual detection biological sensor for RNA detection has been developed. 
The RNA microchip is rapid, sensitive and easy to use. Selectivity and simultaneous detection 
was demonstrated with both pathogenic RNAs and Head and Cancer markers. The targets were 
selectively and simultaneously detected without cross hybridization. Specificity of the method 
was demonstrated by SNPs discrimination using DENV-1 virus RNA as well as BA RNA to 
probe other regions. Even though our probes are short, they offer high level of specificity on the 
microchip. By using our specific probes, we are able to detection of lacZ mRNA from E. coli total 
RNA with high specificity against glucose-suppressed total RNA. The method is sensitive 
enough (up to fmol level) to detect real RNAs without amplification. 
Direct nucleic acids extraction using a new, simple and rapid NAOH protocol further 
simplifies the method and reduces the cost of production. Detection on the RNA microchip can 
be accomplished in an hour which is a departure from DNA microarray which takes up to 16 
hours for hybridization alone not to mention the processes involved during reverse transcription 
and PCR. 
The method is rapid and can be accomplished in under 1 hour. Further simplification of 
the procedure was accomplished by combining RNA hybridization, RNase H digestion and 
Klenow incorporation step with good results. By consolidating the three steps combined with 
manual spotting (Appendix 1), the method can be used anywhere in the world with minimum 
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requirements. Once, the hybrid probes are made, all what one will need is a heating apparatus 
for temperature controls as the signal can be visually detected. If further signal analysis is re-
quired, no problem, the signal is permanent in comparison with chemiluminescence detection 
and fluorescence detection which requires special instruments and decay within hours due to 
enzyme substrate limit and photobleaching respectively. It is amazing how this procedure is 
easy, versatile and allows fine tuning to fit personal needs. The aforementioned desirable char-
acteristics can be furnished for development of a POC pathogen detection device. 
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8.  CONCLUSIONS AND SIGNFICANCE 
RNA microchips with different signal transduction methods has been developed, charac-
terized and validated. There are several parameters needed to ensure the success of a biologi-
cal biosensor and application thereof. These include selectivity, specificity, sensitivity, rapidity 
and cost effectiveness. While it is for a biological sensor to fulfill all these parameters, a trade off 
is made with the best method at the prevailing circumstances being used. Characterization of 
the RNA chip was accomplished by use of different markers from cancer, pathogens and virus 
RNAs. Test with this broad array of targets ensures the 3’-labeling assay and the detection 
methods there sued can be applied to any kind of RNA from any source, as long as target spe-
cific probes are designed. 
With chemiluminescence detection, selectivity was demonstrated by use of different 
head and neck cancer markers. IL8 and VCAM1 were selectively detected from, synthetic RNA 
mixtures, cancer cell lines and colon cancer samples. There was no cross hybridization ob-
served. Simultaneous detection was also demonstrated by using four different probes. From the 
cancer cell lines, VCAM1 was detected in all samples while IL8 was detected in all except 1 
while IGFBP1 not detected in any of the samples. Specificity of detection was demonstrated by 
the signal profile observed in each cancer samples. For example TU 686 had both VCAM1 and 
IL8 detected while LN 686 had only VCAM1. Detection of the markers in low amount of colon 
cancer without amplification is a measure of sensitivity, specifity and rapidity of the RNA micro-
chip. This is an indication that the method can be used for gene expression profiling and cancer 
diagnosis. DENV virus SNPS discrimination shows how powerful method can be in genotyping. 
Even with 1 or more mutation differences, the serotypes detected individually on the chip. A new 
E. coli total RNA extraction protocol simplifies the procedure further making it a more rapid and 
cost effective method RNA detection, genotyping and gene expression profiling. 
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AuNPs-silver staining afforded visual detection on the RNA microchip is a very attractive 
method with high selectivity, specificity and sensitivity. The signal can be observed with naked 
eye therefore it can be anywhere in the world with minimum requirement. A simple NaOH total 
RNA extraction protocol was also specific on the chip resulting in a cost effective and rapid 
method for RNA detection. The method is fast as detection can be accomplished in ~ 1 hour. 
Combination of RNA hybridization, RNase H and Klenow further simplifies the method without 
signal interference. Reduction of the steps ensures minimal operation which is a good charac-
teristic for a POC device. Selectivity and simultaneous detection was accomplished by sue of 
both cancer biomarkers and pathogenic markers without cross hybridization. The method was 
highly specific as observed with Dengue and Bacillus anthracis SNPs discrimination. The meth-
od exhibited high sensitivity by detection of lacZ mRNA from E. coli total RNAs without amplifi-
cation. Specificity was demonstrated by detection of lacZ mRNA from only IPTG induced RNA 
and not from glucose-suppressed total RNA. Direct detection of RNA using NaOH was simple, 
rapid and specific. The rapid and direct RNA detection shortens the RNA microchip detection 
method: culture growth and harvesting, extraction and detection on the chip can be accom-
plished within 24 hrs without enrichment processes. This is a great improvement from the RNA 
purification procedures and cDNA microarray which require RT-PCR, labeling, purification and 
long hybridization times which are normally 16 hrs. 
These two detection techniques have been tested with many different targets i.e. cancer, 
pathogen and virus by just designing target specific probes. The methods have been well char-
acterized with very desirable sensor characteristics. The methods can therefore find applica-
tions in any RNA studies including gene profiling, cancer detection, pathogen detection, infec-
tious diseases detection, forensic and detection of bioterrorist agents. 
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Figure A1. Manual arraying using MicroCASTer 8-Pin System. 3`-labeling technique gen-
erated a positive on the chip. 
 
